id
stringlengths
7
8
tokens
sequence
ner_tags
sequence
texts
stringlengths
0
8.69k
input_ids
sequence
token_type_ids
sequence
attention_mask
sequence
labels
sequence
14734469
[ "BRAF", "mutations", "are", "frequently", "present", "in", "sporadic", "colorectal", "cancer", "with", "methylated", "hMLH1,", "but", "not", "in", "HNPCC-related", "cancers.", "This", "discrepancy", "of", "BRAF", "mutation", "BRAF", " ", "mutation", "is", "frequently", "present", "in", "sporadic", "colorectal", "cancer", "with", "methylated", "hMLH1,", "but", "not", "in", "hereditary", "nonpolyposis", "colorectal", "cancer.", "\n\n\n", "##", "PURPOSE" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BRAF mutations are frequently present in sporadic colorectal cancer with methylated hMLH1, but not in HNPCC-related cancers. This discrepancy of BRAF mutation BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. ## PURPOSE
[ 2, 11346, 3527, 2032, 5467, 2481, 1922, 13088, 7820, 2539, 1956, 11882, 5833, 1024, 8600, 16, 2308, 2084, 1922, 9888, 7693, 1030, 17, 2712, 5717, 18, 2052, 12156, 1927, 11346, 3979, 11346, 3979, 1977, 5467, 2481, 1922, 13088, 7820, 2539, 1956, 11882, 5833, 1024, 8600, 16, 2308, 2084, 1922, 16321, 24857, 26558, 2420, 1937, 7820, 2539, 18, 7, 7, 5120, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
26925673
[ "Cellular", "proliferation,", "morphology", "and", "cell", "cycle", "analysis", "were", "carried", "out", "in", "addition", "to", "Western", "blotting", "for", "detecting", "total", "Akt", "Akt", " ", "signaling", "leads", "to", "reduction", "of", "apoptosis,", "stimulated", "cell", "growth", "and", "enhanced", "proliferation.", "Ellagic", "acid", "(EA),", "a", "naturally", "occurring", "antioxidant,", "has", "recently", "emerged", "as", "a", "promising", "anti-cancer", "agent." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Cellular proliferation, morphology and cell cycle analysis were carried out in addition to Western blotting for detecting total Akt Akt signaling leads to reduction of apoptosis, stimulated cell growth and enhanced proliferation. Ellagic acid (EA), a naturally occurring antioxidant, has recently emerged as a promising anti-cancer agent.
[ 2, 3689, 4031, 16, 6076, 1930, 2024, 4048, 2333, 1985, 4371, 2397, 1922, 2459, 1942, 4540, 8390, 1958, 9227, 2698, 5496, 5496, 3197, 5029, 1942, 3378, 1927, 4091, 16, 5449, 2024, 2905, 1930, 4256, 4031, 18, 20430, 12550, 2687, 12, 11377, 13, 16, 43, 10414, 6966, 7335, 16, 2258, 3998, 9287, 1966, 43, 6842, 2246, 17, 2539, 5899, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
20646601
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
17096342
[ "Disease", "expression", "in", "hereditary", "nonpolyposis", "colorectal", "cancer", "(HNPCC)", "cannot", "be", "readily", "explained", "by", "mutation", "site", "in", "the", "respective", "DNA", "mismatch", "repair", "genes", "associated", "with", "this", "disorder.", "One", "explanation", "is", "the", "role", "of", "modifying", "genes", "that", "can", "either", "promote", "or", "prevent", "disease", "development", "on", "a", "background", "of", "increased", "risk.", "Two", "single", "nucleotide", "polymorphisms", "in", "MDM2", "and", "TP53", "have", "been", "shown", "to", "be", "associated", "with", "younger", "ages", "of", "disease", "onset", "in", "HNPCC", "(TP53)", "and", "Li-Fraumeni", "syndrome", "(MDM2).", "In", "this", "study", "220", "HNPCC", "patients", "were", "examined,", "from", "Australia", "and", "Poland,", "all", "characterized", "at", "the", "molecular", "level", "to", "determine", "the", "frequency", "of", "the", "MDM2", "SNP309", "T>G", "single", "nucleotide", "polymorphisms", " ", "in", "MDM2", "and", "TP53", "have", "been", "shown", "to", "be", "associated", "with", "younger", "ages", "of", "disease", "onset", "in", "HNPCC", "(TP53)", "and", "Li-Fraumeni", "syndrome", "(MDM2).", "In", "this", "study", "220", "HNPCC", "patients", "were", "examined,", "from", "Australia", "and", "Poland,", "all", "characterized", "at", "the", "molecular", "level", "to", "determine", "the", "frequency", "of", "the", "MDM2", " ", "SNP309", "T>G", "and", "to", "assess", "its", "influence", "on", "disease", "expression.", "The", "results", "were", "then", "pooled", "with", "the", "results", "of", "a", "previous", "study", "to", "assess", "the", "combined", "influence", "of", "the", "MDM2", " ", "SNP309", "T>G", " ", "and", "TP53", "SNP", "R72P.", "A", "significant", "difference", "was", "observed", "between", "CRC", "patients", "and", "unaffected", "MMR", "gene", "mutation", "carriers", "over", "the", "age", "of", "45", "years", "(p", "=", "0.01).", "The", "unaffected", "MMR", "gene", "mutation", "carriers", "over", "the", "age", "of", "45", "years", "who", "carry", "the", "G", "allele", "have", "a", "reduced", "risk", "of", "developing", "CRC.", "The", "results", "indicate", "that", "the", "MDM2", "SNP309,", "alone", "or", "in", "combination", "with", "TP53", "R72P,", "does", "not", "influence", "age", "of", "diagnosis", "of", "CRC", "in", "individuals", "with", "HNPCC.", "In", "conclusion,", "the", "data", "indicates", "the", "G", "allele", "of", "MDM2", "SNP309", "might", "have", "a", "protective", "effect", "on", "disease", "development", "in", "HNPCC", "patients", "and", "that", "age", "of", "diagnosis", "of", "CRC", "is", "not", "associated", "with", "MDM2", "SNP309", "or", "TP53", "R72P", "either", "as", "single", "SNPs", "SNP", "TP53", " ", "SNP", "R72P.", "A", "significant", "difference", "was", "observed", "between", "CRC", "patients", "and", "unaffected", "MMR", "gene", "mutation", "carriers", "over", "the", "age", "of", "45", "years", "(p", "=", "0.01).", "The", "unaffected", "MMR", "gene", "mutation", "carriers", "over", "the", "age", "of", "45", "years", "who", "carry", "the", "G", "allele", "have", "a", "reduced", "risk", "of", "developing", "CRC.", "The", "results", "indicate", "that", "the", "MDM2", " ", "SNP309", "mutation", " ", "carriers", "over", "the", "age", "of", "45", "years", "who", "carry", "the", "G", "allele", "have", "a", "reduced", "risk", "of", "developing", "CRC.", "The", "results", "indicate", "that", "the", "MDM2", "SNP309,", "alone", "or", "in", "combination", "with", "TP53", "MMR", "MMR", " ", "gene", "mutation", "carriers", "over", "the", "age", "of", "45", "years", "(p", "=", "0.01).", "The", "unaffected", "MMR", "gene", "mutation", "carriers", "over", "the", "age", "of", "45", "years", "who", "carry", "the", "G", "allele", "have", "a", "reduced", "risk", "of", "developing", "CRC.", "The", "results", "indicate", "that", "the", "MDM2", "SNP309,", "alone", "or", "in", "combination", "with", "TP53", "R72P,", "does", "not", "influence", "age", "of", "diagnosis", "of", "CRC", "in", "individuals", "with", "HNPCC.", "In", "conclusion,", "the", "data", "indicates", "the", "G", "allele", "of", "MDM2", "SNP309", "might", "have", "a", "protective", "effect", "on", "disease", "development", "in", "HNPCC", "patients", "and", "that", "age", "of", "diagnosis", "of", "CRC", "is", "not", "associated", "with", "MDM2", "SNP309", "or", "TP53", "R72P", "either", "as", "single", "SNPs", "or", "combined." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Disease expression in hereditary nonpolyposis colorectal cancer (HNPCC) cannot be readily explained by mutation site in the respective DNA mismatch repair genes associated with this disorder. One explanation is the role of modifying genes that can either promote or prevent disease development on a background of increased risk. Two single nucleotide polymorphisms in MDM2 and TP53 have been shown to be associated with younger ages of disease onset in HNPCC (TP53) and Li-Fraumeni syndrome (MDM2). In this study 220 HNPCC patients were examined, from Australia and Poland, all characterized at the molecular level to determine the frequency of the MDM2 SNP309 T>G single nucleotide polymorphisms in MDM2 and TP53 have been shown to be associated with younger ages of disease onset in HNPCC (TP53) and Li-Fraumeni syndrome (MDM2). In this study 220 HNPCC patients were examined, from Australia and Poland, all characterized at the molecular level to determine the frequency of the MDM2 SNP309 T>G and to assess its influence on disease expression. The results were then pooled with the results of a previous study to assess the combined influence of the MDM2 SNP309 T>G and TP53 SNP R72P. A significant difference was observed between CRC patients and unaffected MMR gene mutation carriers over the age of 45 years (p = 0.01). The unaffected MMR gene mutation carriers over the age of 45 years who carry the G allele have a reduced risk of developing CRC. The results indicate that the MDM2 SNP309, alone or in combination with TP53 R72P, does not influence age of diagnosis of CRC in individuals with HNPCC. In conclusion, the data indicates the G allele of MDM2 SNP309 might have a protective effect on disease development in HNPCC patients and that age of diagnosis of CRC is not associated with MDM2 SNP309 or TP53 R72P either as single SNPs SNP TP53 SNP R72P. A significant difference was observed between CRC patients and unaffected MMR gene mutation carriers over the age of 45 years (p = 0.01). The unaffected MMR gene mutation carriers over the age of 45 years who carry the G allele have a reduced risk of developing CRC. The results indicate that the MDM2 SNP309 mutation carriers over the age of 45 years who carry the G allele have a reduced risk of developing CRC. The results indicate that the MDM2 SNP309, alone or in combination with TP53 MMR MMR gene mutation carriers over the age of 45 years (p = 0.01). The unaffected MMR gene mutation carriers over the age of 45 years who carry the G allele have a reduced risk of developing CRC. The results indicate that the MDM2 SNP309, alone or in combination with TP53 R72P, does not influence age of diagnosis of CRC in individuals with HNPCC. In conclusion, the data indicates the G allele of MDM2 SNP309 might have a protective effect on disease development in HNPCC patients and that age of diagnosis of CRC is not associated with MDM2 SNP309 or TP53 R72P either as single SNPs or combined.
[ 2, 2573, 2294, 1922, 16321, 24857, 26558, 2420, 1937, 7820, 2539, 12, 9888, 7693, 1030, 13, 5156, 1998, 8745, 6094, 2007, 3979, 3200, 1922, 1920, 7025, 2678, 10265, 5059, 2628, 2458, 1956, 2052, 4770, 18, 2340, 8042, 1977, 1920, 2770, 1927, 12691, 2628, 1988, 2112, 3108, 5527, 2014, 4625, 2573, 2740, 1990, 43, 3872, 1927, 2502, 2565, 18, 2288, 2957, 5489, 8321, 1922, 13659, 1930, 13544, 2162, 2252, 2522, 1942, 1998, 2458, 1956, 7237, 7684, 1927, 2573, 4727, 1922, 9888, 7693, 1030, 12, 13544, 13, 1930, 2336, 17, 23228, 16120, 8635, 4741, 12, 13659, 13, 18, 1922, 2052, 2161, 12391, 9888, 7693, 1030, 2132, 1985, 3572, 16, 2037, 10014, 1930, 19603, 16, 2136, 4378, 2019, 1920, 3272, 2237, 1942, 3415, 1920, 3528, 1927, 1920, 13659, 6821, 26494, 62, 34, 49, 2957, 5489, 8321, 1922, 13659, 1930, 13544, 2162, 2252, 2522, 1942, 1998, 2458, 1956, 7237, 7684, 1927, 2573, 4727, 1922, 9888, 7693, 1030, 12, 13544, 13, 1930, 2336, 17, 23228, 16120, 8635, 4741, 12, 13659, 13, 18, 1922, 2052, 2161, 12391, 9888, 7693, 1030, 2132, 1985, 3572, 16, 2037, 10014, 1930, 19603, 16, 2136, 4378, 2019, 1920, 3272, 2237, 1942, 3415, 1920, 3528, 1927, 1920, 13659, 6821, 26494, 62, 34, 49, 1930, 1942, 2634, 2496, 4039, 1990, 2573, 2294, 18, 1920, 2274, 1985, 2759, 7803, 1956, 1920, 2274, 1927, 43, 2555, 2161, 1942, 2634, 1920, 4252, 4039, 1927, 1920, 13659, 6821, 26494, 62, 34, 49, 1930, 13544, 6821, 29396, 17999, 18, 43, 2228, 3175, 1982, 2528, 2192, 8223, 2132, 1930, 10403, 16744, 2359, 3979, 8974, 2338, 1920, 2632, 1927, 3607, 2739, 12, 58, 33, 20, 18, 3287, 13, 18, 1920, 10403, 16744, 2359, 3979, 8974, 2338, 1920, 2632, 1927, 3607, 2739, 2746, 9875, 1920, 49, 5465, 2162, 43, 3028, 2565, 1927, 5130, 8223, 18, 1920, 2274, 3579, 1988, 1920, 13659, 6821, 26494, 16, 4298, 2014, 1922, 3921, 1956, 13544, 29396, 17999, 16, 3731, 2084, 4039, 2632, 1927, 3574, 1927, 8223, 1922, 3445, 1956, 9888, 7693, 1030, 18, 1922, 4180, 16, 1920, 2230, 4538, 1920, 49, 5465, 1927, 13659, 6821, 26494, 3284, 2162, 43, 6337, 2495, 1990, 2573, 2740, 1922, 9888, 7693, 1030, 2132, 1930, 1988, 2632, 1927, 3574, 1927, 8223, 1977, 2084, 2458, 1956, 13659, 6821, 26494, 2014, 13544, 29396, 17999, 3108, 1966, 2957, 6084, 6821, 13544, 6821, 29396, 17999, 18, 43, 2228, 3175, 1982, 2528, 2192, 8223, 2132, 1930, 10403, 16744, 2359, 3979, 8974, 2338, 1920, 2632, 1927, 3607, 2739, 12, 58, 33, 20, 18, 3287, 13, 18, 1920, 10403, 16744, 2359, 3979, 8974, 2338, 1920, 2632, 1927, 3607, 2739, 2746, 9875, 1920, 49, 5465, 2162, 43, 3028, 2565, 1927, 5130, 8223, 18, 1920, 2274, 3579, 1988, 1920, 13659, 6821, 26494, 3979, 8974, 2338, 1920, 2632, 1927, 3607, 2739, 2746, 9875, 1920, 49, 5465, 2162, 43, 3028, 2565, 1927, 5130, 8223, 18, 1920, 2274, 3579, 1988, 1920, 13659, 6821, 26494, 16, 4298, 2014, 1922, 3921, 1956, 13544, 16744, 16744, 2359, 3979, 8974, 2338, 1920, 2632, 1927, 3607, 2739, 12, 58, 33, 20, 18, 3287, 13, 18, 1920, 10403, 16744, 2359, 3979, 8974, 2338, 1920, 2632, 1927, 3607, 2739, 2746, 9875, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 4, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 4, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
23012243
[ "Lynch", "syndrome", "is", "characterized", "by", "mutations", "in", "one", "of", "four", "mismatch", "repair", "genes,", "MLH1,", "MSH2,", "MSH6,", "or", "PMS2.", "Clinical", "mutation", "analysis", "of", "these", "genes", "includes", "sequencing", "of", "exonic", "regions", "and", "deletion/duplication", "analysis.", "However,", "detection", "of", "deletions", "and", "duplications", "in", "PMS2", "has", "previously", "been", "confined", "to", "Exons", "1-11", "due", "to", "gene", "conversion", "between", "PMS2", "and", "the", "pseudogene", "PMS2CL", "in", "the", "remaining", "3'", "exons", "(Exons", "12-15).", "We", "have", "recently", "described", "an", "MLPA-based", "method", "that", "permits", "detection", "of", "deletions", "of", "PMS2", "Exons", "12-15;", "however,", "the", "frequency", "of", "such", "deletions", "has", "not", "yet", "been", "determined.", "To", "address", "this", "question,", "we", "tested", "for", "3'", " ", "deletions", "in", "58", "samples", "that", "were", "reported", "to", "be", "negative", "for", "PMS2", "mutations", "using", "previously", "available", "methods.", "All", "samples", "were", "from", "individuals", "whose", "tumors", "exhibited", "loss", "of", "PMS2", "immunohistochemical", "staining", "without", "concomitant", "loss", "of", "MLH1", "immunostaining.", "We", "identified", "seven", "samples", "in", "this", "cohort", "with", "deletions", "in", "the", "3'", "region", "of", "PMS2,", "including", "three", "previously", "reported", "samples", "with", "deletions", "of", "Exons", "13-15", "(two", "samples)", "and", "Exons", "14-15.", "Also", "detected", "were", "deletions", "deletion", "/duplication", "analysis.", "However,", "detection", "of", "deletions", " ", "and", "duplications", "in", "PMS2", " ", "has", "previously", "been", "confined", "to", "Exons", "1-11", "due", "to", "gene", "conversion", "between", "PMS2", "and", "the", "pseudogene", "PMS2CL", "in", "the", "remaining", "3'", "exons", "(Exons", "12-15).", "We", "have", "recently", "described", "an", "MLPA-based", "method", "that", "permits", "detection", "of", "deletions", "of", "PMS2", "Exons", "12-15;", "however,", "the", "frequency", "of", "such", "deletions", "has", "not", "yet", "been", "determined.", "To", "address", "this", "question,", "we", "tested", "for", "3'", "deletions", "in", "58", "samples", "that", "were", "reported", "to", "be", "negative", "for", "PMS2", "mutations", "using", "previously", "available", "methods.", "All", "samples", "were", "from", "individuals", "whose", "tumors", "exhibited", "loss", "of", "PMS2", "immunohistochemical", "staining", "without", "concomitant", "loss", "of", "MLH1", "immunostaining.", "We", "identified", "seven", "samples", "in", "this", "cohort", "with", "deletions", "in", "the", "3'", "region", "of", "PMS2,", "including", "three", "previously", "reported", "samples", "with", "deletions", "of", "Exons", "13-15", "(two", "samples)", "and", "Exons", "14-15", "duplication", " ", "analysis.", "However,", "detection", "of", "deletions", "and", "duplications", " ", "in", "PMS2", "has", "previously", "been", "confined", "to", "Exons", "1-11", "due", "to", "gene", "conversion", "between", "PMS2", "and", "the", "pseudogene", "PMS2CL", "in", "the", "remaining", "3'", "exons", "(Exons", "12-15).", "We", "have", "recently", "described", "an", "MLPA-based", "method", "that", "permits", "detection", "of", "deletions", "of", "PMS2", "Exons", "12-15;", "however,", "the", "frequency", "of", "such", "deletions", "has", "not", "yet", "been", "determined.", "To", "address", "this", "question,", "we", "tested", "for", "3'", "deletions", "in", "58", "samples", "that", "were", "reported", "to", "be", "negative", "for", "PMS2", "mutations", "using", "previously", "available", "methods.", "All", "samples", "were", "from", "individuals", "whose", "tumors", "exhibited", "loss", "of", "PMS2", "immunohistochemical", "staining", "without", "concomitant", "loss", "of", "MLH1", "immunostaining.", "We", "identified", "seven", "samples", "in", "this", "cohort", "with", "deletions", "in", "the", "3'", "region", "of", "PMS2,", "including", "three", "previously", "reported", "samples", "with", "deletions", "of", "Exons", "13-15", "(two", "samples)", "and", "Exons", "14-15.", "Also", "detected", "were", "deletions", "of", "Exons", "12-15,", "Exon", "13", "3'", "exons", "PMS2CL", " ", "in", "the", "remaining", "3'", "exons", "(Exons", "12-15).", "We", "have", "recently", "described", "an", "MLPA-based", "method", "that", "permits", "detection", "of", "deletions", "of", "PMS2", "Exons", "12-15;", "however,", "the", "frequency", "of", "such", "deletions", "has", "not", "yet", "been", "determined.", "To", "address", "this", "question,", "we", "tested", "for", "3'", "deletions", "in", "58", "samples", "that", "were", "reported", "to", "be", "negative", "for", "PMS2", "mutations", "using", "previously", "available", "methods.", "All", "samples", "were", "from", "individuals", "whose", "tumors", "exhibited", "loss", "of", "PMS2", "immunohistochemical", "staining", "without", "concomitant", "loss", "of", "MLH1", "immunostaining.", "We", "identified", "seven", "samples", "in", "this", "cohort", "with", "deletions", "in", "the", "3'", "region", "of", "PMS2,", "including", "three", "previously", "reported", "samples", "with", "deletions", "of", "Exons", "13-15", "(two", "samples)", "and", "Exons", "14-15.", "Also", "detected", "were", "deletions", "of", "Exons", "12-15", "PMS2", " ", "and", "the", "pseudogene", "PMS2CL", "in", "the", "remaining", "3'", "exons", "(Exons", "12-15).", "We", "have", "recently", "described", "an", "MLPA-based", "method", "that", "permits", "detection", "of", "deletions", "of", "PMS2", "Exons", "12-15;", "however,", "the", "frequency", "of", "such", "deletions", "has", "not", "yet", "been", "determined.", "To", "address", "this", "question,", "we", "tested", "for", "3'", "deletions", "in", "58", "samples", "that", "were", "reported", "to", "be", "negative", "for", "PMS2", "mutations", "using", "previously", "available", "methods.", "All", "samples", "were", "from", "individuals", "whose", "tumors", "exhibited", "loss", "of", "PMS2", "immunohistochemical", "staining", "without", "concomitant", "loss", "of", "MLH1", "immunostaining.", "We", "identified", "seven", "samples", "in", "this", "cohort", "with", "deletions", "in", "the", "3'", "region", "of", "PMS2,", "including", "three", "previously", "reported", "samples", "with", "deletions", "of", "Exons", "13-15", "(two", "samples)", "and", "Exons", "14-15.", "Also", "detected", "were", "deletions", "of", "Exons", "12-15,", "Exon", "13,", "and", "Exon", "14", "(two", "samples).", "Breakpoint", "analysis", "of", "the", "intragenic", "deletions", "mutations", "deletions", " ", "has", "not", "yet", "been", "determined.", "To", "address", "this", "question,", "we", "tested", "for", "3'", "deletions", "in", "58", "samples", "that", "were", "reported", "to", "be", "negative", "for", "PMS2", "deletions", " ", "in", "58", "samples", "that", "were", "reported", "to", "be", "negative", "for", "PMS2", "mutations", "using", "previously", "available", "methods.", "All", "samples", "were", "from", "individuals", "whose", "tumors", "exhibited", "loss", "of", "PMS2", "immunohistochemical", "staining", "without", "concomitant", "loss", "of", "MLH1", "PMS2", " ", "immunohistochemical", "staining", "without", "concomitant", "loss", "of", "MLH1", "immunostaining.", "We", "identified", "seven", "samples", "in", "this", "cohort", "with", "deletions", " ", "in", "the", "3'", "region", "of", "PMS2,", "including", "three", "previously", "reported", "samples", "with", "deletions", "PMS2", ",", "including", "three", "previously", "reported", "samples", "with", "deletions", "of", "Exons", "13-15", "(two", "samples)", "and", "Exons", "14-15.", "Also", "detected", "were", "deletions", "of", "Exons", "12-15,", "Exon", "13,", "and", "Exon", "14", "deletions", " ", "involving", "3'", "Exons", "of", "the", "PMS2", "gene." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 3, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 7, 8, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
Lynch syndrome is characterized by mutations in one of four mismatch repair genes, MLH1, MSH2, MSH6, or PMS2. Clinical mutation analysis of these genes includes sequencing of exonic regions and deletion/duplication analysis. However, detection of deletions and duplications in PMS2 has previously been confined to Exons 1-11 due to gene conversion between PMS2 and the pseudogene PMS2CL in the remaining 3' exons (Exons 12-15). We have recently described an MLPA-based method that permits detection of deletions of PMS2 Exons 12-15; however, the frequency of such deletions has not yet been determined. To address this question, we tested for 3' deletions in 58 samples that were reported to be negative for PMS2 mutations using previously available methods. All samples were from individuals whose tumors exhibited loss of PMS2 immunohistochemical staining without concomitant loss of MLH1 immunostaining. We identified seven samples in this cohort with deletions in the 3' region of PMS2, including three previously reported samples with deletions of Exons 13-15 (two samples) and Exons 14-15. Also detected were deletions deletion /duplication analysis. However, detection of deletions and duplications in PMS2 has previously been confined to Exons 1-11 due to gene conversion between PMS2 and the pseudogene PMS2CL in the remaining 3' exons (Exons 12-15). We have recently described an MLPA-based method that permits detection of deletions of PMS2 Exons 12-15; however, the frequency of such deletions has not yet been determined. To address this question, we tested for 3' deletions in 58 samples that were reported to be negative for PMS2 mutations using previously available methods. All samples were from individuals whose tumors exhibited loss of PMS2 immunohistochemical staining without concomitant loss of MLH1 immunostaining. We identified seven samples in this cohort with deletions in the 3' region of PMS2, including three previously reported samples with deletions of Exons 13-15 (two samples) and Exons 14-15 duplication analysis. However, detection of deletions and duplications in PMS2 has previously been confined to Exons 1-11 due to gene conversion between PMS2 and the pseudogene PMS2CL in the remaining 3' exons (Exons 12-15). We have recently described an MLPA-based method that permits detection of deletions of PMS2 Exons 12-15; however, the frequency of such deletions has not yet been determined. To address this question, we tested for 3' deletions in 58 samples that were reported to be negative for PMS2 mutations using previously available methods. All samples were from individuals whose tumors exhibited loss of PMS2 immunohistochemical staining without concomitant loss of MLH1 immunostaining. We identified seven samples in this cohort with deletions in the 3' region of PMS2, including three previously reported samples with deletions of Exons 13-15 (two samples) and Exons 14-15. Also detected were deletions of Exons 12-15, Exon 13 3' exons PMS2CL in the remaining 3' exons (Exons 12-15). We have recently described an MLPA-based method that permits detection of deletions of PMS2 Exons 12-15; however, the frequency of such deletions has not yet been determined. To address this question, we tested for 3' deletions in 58 samples that were reported to be negative for PMS2 mutations using previously available methods. All samples were from individuals whose tumors exhibited loss of PMS2 immunohistochemical staining without concomitant loss of MLH1 immunostaining. We identified seven samples in this cohort with deletions in the 3' region of PMS2, including three previously reported samples with deletions of Exons 13-15 (two samples) and Exons 14-15. Also detected were deletions of Exons 12-15 PMS2 and the pseudogene PMS2CL in the remaining 3' exons (Exons 12-15). We have recently described an MLPA-based method that permits detection of deletions of PMS2 Exons 12-15; however, the frequency of such deletions has not yet been determined. To address this question, we tested for 3' deletions in 58 samples that were reported to be negative for PMS2 mutations using previously available methods. All samples were from individuals whose tumors exhibited loss of PMS2 immunohistochemical staining without concomitant loss of MLH1 immunostaining. We identified seven samples in this cohort with deletions in the 3' region of PMS2, including three previously reported samples with deletions of Exons 13-15 (two samples) and Exons 14-15. Also detected were deletions of Exons 12-15, Exon 13, and Exon 14 (two samples). Breakpoint analysis of the intragenic deletions mutations deletions has not yet been determined. To address this question, we tested for 3' deletions in 58 samples that were reported to be negative for PMS2 deletions in 58 samples that were reported to be negative for PMS2 mutations using previously available methods. All samples were from individuals whose tumors exhibited loss of PMS2 immunohistochemical staining without concomitant loss of MLH1 PMS2 immunohistochemical staining without concomitant loss of MLH1 immunostaining. We identified seven samples in this cohort with deletions in the 3' region of PMS2, including three previously reported samples with deletions PMS2 , including three previously reported samples with deletions of Exons 13-15 (two samples) and Exons 14-15. Also detected were deletions of Exons 12-15, Exon 13, and Exon 14 deletions involving 3' Exons of the PMS2 gene.
[ 2, 27452, 4741, 1977, 4378, 2007, 3527, 1922, 2340, 1927, 3006, 10265, 5059, 2628, 16, 25265, 16, 26693, 16, 19864, 1016, 16, 2014, 13673, 1028, 18, 2535, 3979, 2333, 1927, 2144, 2628, 5921, 4754, 1927, 29070, 3451, 1930, 5541, 19, 12630, 2333, 18, 2406, 16, 3805, 1927, 10550, 1930, 20559, 1922, 13673, 1028, 2258, 3024, 2252, 13184, 1942, 10419, 21, 17, 2513, 2810, 1942, 2359, 7309, 2192, 13673, 1028, 1930, 1920, 11520, 14687, 13673, 10866, 1024, 1922, 1920, 5719, 23, 11, 10419, 12, 10419, 2369, 17, 2461, 13, 18, 2038, 2162, 3998, 2910, 1925, 2646, 4302, 17, 2454, 2417, 1988, 16299, 3805, 1927, 10550, 1927, 13673, 1028, 10419, 2369, 17, 2461, 31, 2406, 16, 1920, 3528, 1927, 2427, 10550, 2258, 2084, 4898, 2252, 3180, 18, 1942, 4640, 2052, 3863, 16, 2038, 3620, 1958, 23, 11, 10550, 1922, 4804, 2785, 1988, 1985, 2568, 1942, 1998, 3136, 1958, 13673, 1028, 3527, 2193, 3024, 3322, 2860, 18, 2136, 2785, 1985, 2037, 3445, 6098, 3861, 5065, 3257, 1927, 13673, 1028, 9885, 4166, 2979, 8537, 3257, 1927, 25265, 10930, 18, 2038, 2899, 5260, 2785, 1922, 2052, 4382, 1956, 10550, 1922, 1920, 23, 11, 3031, 1927, 13673, 1028, 16, 2710, 2559, 3024, 2568, 2785, 1956, 10550, 1927, 10419, 2590, 17, 2461, 12, 2288, 2785, 13, 1930, 10419, 2607, 17, 2461, 18, 2222, 3330, 1985, 10550, 5541, 19, 12630, 2333, 18, 2406, 16, 3805, 1927, 10550, 1930, 20559, 1922, 13673, 1028, 2258, 3024, 2252, 13184, 1942, 10419, 21, 17, 2513, 2810, 1942, 2359, 7309, 2192, 13673, 1028, 1930, 1920, 11520, 14687, 13673, 10866, 1024, 1922, 1920, 5719, 23, 11, 10419, 12, 10419, 2369, 17, 2461, 13, 18, 2038, 2162, 3998, 2910, 1925, 2646, 4302, 17, 2454, 2417, 1988, 16299, 3805, 1927, 10550, 1927, 13673, 1028, 10419, 2369, 17, 2461, 31, 2406, 16, 1920, 3528, 1927, 2427, 10550, 2258, 2084, 4898, 2252, 3180, 18, 1942, 4640, 2052, 3863, 16, 2038, 3620, 1958, 23, 11, 10550, 1922, 4804, 2785, 1988, 1985, 2568, 1942, 1998, 3136, 1958, 13673, 1028, 3527, 2193, 3024, 3322, 2860, 18, 2136, 2785, 1985, 2037, 3445, 6098, 3861, 5065, 3257, 1927, 13673, 1028, 9885, 4166, 2979, 8537, 3257, 1927, 25265, 10930, 18, 2038, 2899, 5260, 2785, 1922, 2052, 4382, 1956, 10550, 1922, 1920, 23, 11, 3031, 1927, 13673, 1028, 16, 2710, 2559, 3024, 2568, 2785, 1956, 10550, 1927, 10419, 2590, 17, 2461, 12, 2288, 2785, 13, 1930, 10419, 2607, 17, 2461, 12630, 2333, 18, 2406, 16, 3805, 1927, 10550, 1930, 20559, 1922, 13673, 1028, 2258, 3024, 2252, 13184, 1942, 10419, 21, 17, 2513, 2810, 1942, 2359, 7309, 2192, 13673, 1028, 1930, 1920, 11520, 14687, 13673, 10866, 1024, 1922, 1920, 5719, 23, 11, 10419, 12, 10419, 2369, 17, 2461, 13, 18, 2038, 2162, 3998, 2910, 1925, 2646, 4302, 17, 2454, 2417, 1988, 16299, 3805, 1927, 10550, 1927, 13673, 1028, 10419, 2369, 17, 2461, 31, 2406, 16, 1920, 3528, 1927, 2427, 10550, 2258, 2084, 4898, 2252, 3180, 18, 1942, 4640, 2052, 3863, 16, 2038, 3620, 1958, 23, 11, 10550, 1922, 4804, 2785, 1988, 1985, 2568, 1942, 1998, 3136, 1958, 13673, 1028, 3527, 2193, 3024, 3322, 2860, 18, 2136, 2785, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 8, 3, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
24196785
[ "Amplification", "of", "PVT-1", "is", "involved", "in", "poor", "prognosis", "via", "apoptosis", "inhibition", "in", "colorectal", "cancers.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. ## BACKGROUND
[ 2, 6584, 1927, 5774, 1031, 17, 21, 1977, 3286, 1922, 3930, 6573, 3454, 4091, 3523, 1922, 7820, 5717, 18, 7, 7, 3872, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
17454882
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
9841584
[ "Life", "expectancy", "and", "quality-adjusted", "life", "expectancy." ]
[ 0, 0, 0, 0, 0, 0 ]
Life expectancy and quality-adjusted life expectancy.
[ 2, 3308, 15227, 1930, 3455, 17, 4967, 3308, 15227, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
22810479
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
26302849
[ "##", "METHODS" ]
[ 0, 0 ]
## METHODS
[ 2, 7, 7, 2860, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
19276868
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
9476377
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
22810479
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
20646601
[ "##", "METHODS" ]
[ 0, 0 ]
## METHODS
[ 2, 7, 7, 2860, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
26302849
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
20198339
[ "Bile", "acid", "regulates", "MUC2", "transcription", "in", "colon", "cancer", "cells", "via", "positive", "EGFR/PKC/Ras/ERK/CREB,", "PI3K/Akt/IkappaB/NF-kappaB", "and", "p38/MSK1/CREB", "pathways", "and", "negative", "JNK/c-Jun/AP-1", "pathway." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway.
[ 2, 9619, 2687, 7014, 3422, 1028, 3213, 1922, 4120, 2539, 2094, 3454, 2843, 5775, 19, 8425, 19, 6520, 19, 7770, 19, 13268, 16, 7734, 19, 5496, 19, 14502, 3444, 1993, 19, 4651, 17, 19901, 1930, 8723, 19, 3012, 4835, 19, 13268, 3873, 1930, 3136, 10063, 19, 45, 17, 7269, 19, 2100, 17, 21, 3374, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
12534642
[ "In", "114", "samples,", "the", "most", "frequent", "CYP1A2", "SNPs", "were", "1545T-->C", "(38.2%", "of", "tested", "chromosomes),", "-164A-->C", " ", "(", "CYP1A2*1F", "CYP1A2*2", "),", "and", "1545T-->C", "(alleles", "CYP1A2*1B,", "*1G,", "*1H", "and", "*3),", "using", "polymerase", "chain", "reaction-restriction", "fragment", "length", "polymorphism", "assays.", "All", "patients", "and", "controls", "were", "phenotyped", "for", "CYP1A2", "by", "h.p.l.c.", "analysis", "of", "urinary", "caffeine", "metabolites." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
In 114 samples, the most frequent CYP1A2 SNPs were 1545T-->C (38.2% of tested chromosomes), -164A-->C ( CYP1A2*1F CYP1A2*2 ), and 1545T-->C (alleles CYP1A2*1B, *1G, *1H and *3), using polymerase chain reaction-restriction fragment length polymorphism assays. All patients and controls were phenotyped for CYP1A2 by h.p.l.c. analysis of urinary caffeine metabolites.
[ 2, 1922, 11296, 2785, 16, 1920, 2501, 6439, 6120, 23750, 6084, 1985, 14396, 1015, 1031, 17, 17, 34, 45, 12, 3738, 18, 22, 9, 1927, 3620, 8597, 13, 16, 17, 15170, 1019, 17, 17, 34, 45, 12, 6120, 23750, 14, 14078, 6120, 23750, 14, 22, 13, 16, 1930, 14396, 1015, 1031, 17, 17, 34, 45, 12, 7096, 6120, 23750, 14, 5462, 16, 14, 15957, 16, 14, 5189, 1930, 14, 23, 13, 16, 2193, 6479, 4659, 3227, 17, 7587, 5302, 3471, 8218, 4614, 18, 2136, 2132, 1930, 3562, 1985, 4629, 1007, 1958, 6120, 23750, 2007, 50, 18, 58, 18, 54, 18, 45, 18, 2333, 1927, 7075, 14119, 6926, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 4, 4, 4, 4, 0, 3, 4, 4, 4, 3, 4, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
14734469
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
26416897
[ "TBK1", "rs7486100", "was", "significantly", "associated", "with", "overall", "survival", "in", "95", "KRAS", "wild-type", "patients", "of", "TRIBE", "cohort", "in", "univariate", "analysis", "and", "had", "a", "strong", "trend", "in", "multivariable", "analysis;", "furthermore,", "the", "association", "of", "the", "T", "allele", "was", "observed", "for", "progression-free", "survival", "(PFS)", "in", "both", "univariate", "and", "multivariable", "analyses", "in", "FIRE3-bevacizumab", "but", "not", "cetuximab", "cohort.", "CCL2", "rs4586,", "CCL18", "rs14304,", "and", "IRF3", "rs2304205", "had", "univariate", "and", "multivariable", "correlations", "with", "PFS", "in", "KRAS", "rs14304", ",", "and", "IRF3", "rs2304205", "had", "univariate", "and", "multivariable", "correlations", "with", "PFS", "in", "KRAS", "mutant", "patients", "of", "the", "TRIBE", "cohort,", "whereas", "they", "had", "no", "correlations", "in", "KRAS", "wild-type", "patients", "of", "the", "TRIBE", "cohort.", "No", "association", "was", "seen", "in", "control", "cohort." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 11, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
TBK1 rs7486100 was significantly associated with overall survival in 95 KRAS wild-type patients of TRIBE cohort in univariate analysis and had a strong trend in multivariable analysis; furthermore, the association of the T allele was observed for progression-free survival (PFS) in both univariate and multivariable analyses in FIRE3-bevacizumab but not cetuximab cohort. CCL2 rs4586, CCL18 rs14304, and IRF3 rs2304205 had univariate and multivariable correlations with PFS in KRAS rs14304 , and IRF3 rs2304205 had univariate and multivariable correlations with PFS in KRAS mutant patients of the TRIBE cohort, whereas they had no correlations in KRAS wild-type patients of the TRIBE cohort. No association was seen in control cohort.
[ 2, 28847, 26570, 28839, 9029, 1982, 2567, 2458, 1956, 3399, 3298, 1922, 3002, 11083, 3576, 17, 2601, 2132, 1927, 14521, 1021, 4382, 1922, 9895, 2333, 1930, 2430, 43, 3206, 5045, 1922, 11327, 2333, 31, 3677, 16, 1920, 3279, 1927, 1920, 62, 5465, 1982, 2528, 1958, 4380, 17, 3294, 3298, 12, 11133, 13, 1922, 2321, 9895, 1930, 11327, 3247, 1922, 11105, 1010, 17, 15250, 2308, 2084, 19418, 4382, 18, 18280, 4366, 6803, 11617, 16, 10322, 3928, 4366, 24428, 14743, 16, 1930, 23827, 4366, 4553, 14743, 23368, 2430, 9895, 1930, 11327, 6100, 1956, 11133, 1922, 11083, 4366, 24428, 14743, 16, 1930, 23827, 4366, 4553, 14743, 23368, 2430, 9895, 1930, 11327, 6100, 1956, 11133, 1922, 11083, 3606, 2132, 1927, 1920, 14521, 1021, 4382, 16, 3417, 2611, 2430, 2239, 6100, 1922, 11083, 3576, 17, 2601, 2132, 1927, 1920, 14521, 1021, 4382, 18, 2239, 3279, 1982, 3945, 1922, 2285, 4382, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 11, 12, 12, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
1916131
[ "Evidence", "is", "accumulating", "that", "the", "p53", " ", "anti-oncogene", "is", "a", "key", "gene", "in", "the", "genesis", "of", "carcinoma", "in", "human", "colon", "and", "rectum.", "Although", "mutations", " ", "of", "the", "p53", "gene", "have", "been", "shown", "to", "be", "frequent,", "the", "protein", "was", "present", "in", "only", "approximately", "50", "percent", "of", "specimens", "examined.", "However", "only", "one", "monoclonal", "antibody", "recognizing", "an", "epitope", "present", "on", "wild-type", "p53", "had", "been", "used.", "We", "studied", "the", "p53", "expression", "in", "a", "series", "of", "16", "colorectal", "carcinoma", "specimens", "using", "3", "different", "monoclonal", "antibodies", "(pAb", "421,", "1801,", "240).", "Specific", "immunofluorescent", "staining", "was", "quantified", "by", "dual", "parameter", "(DNA/p53)", "flow", "cytometry.", "Two", "different", "types", "of", "preparations", "were", "compared", "in", "order", "to", "verify", "the", "conservation", "of", "the", "antigen.", "Nuclear", "suspensions", "prepared", "from", "frozen", "tumor", "fragments", "were", "shown", "to", "produce", "results", "equivalent", "to", "those", "of", "whole", "cell", "preparations", "originating", "from", "fresh", "surgical", "specimens.", "The", "p53", "protein", "was", "detected", "in", "9", "of", "the", "16", "cancers", "with", "pAb", "421", "and", "240", "monoclonal", "antibodies", "(8", "of", "which", "were", "also", "positive", "for", "pAb", "1801", "antibody).", "Four", "additional", "tumors", "were", "considered", "positive", "for", "pAb", "240", "antibody", "alone.", "Overall,", "13/16", "cancer", "specimens", "were", "shown", "to", "present", "immunoreactivity", "for", "pAb", "240", "antibody.", "Topography", "of", "staining", "was", "investigated", "by", "immunohistochemistry", "with", "peroxidase", "methods.", "Eight", "cases", "were", "informative,", "6", "of", "which", "presented", "nuclear", "staining", "compatible", "with", "the", "cytometry", "results.", "There", "was", "one", "discordant", "case", "i.e.", "pAb", "240", "antibody", "being", "positive", "on", "cytometry", "and", "entirely", "negative", "on", "immunohistochemistry.", "This", "small", "series", "allowed", "us", "to", "show", "that", "81", "percent", "of", "tumor", "samples", "stained", "with", "monoclonal", "antibody", "pAb", "240,", "considered", "to", "be", "specific", "to", "mutated", "pAb", "240", "pAb", "240", "p53", ")", "flow", "cytometry.", "Two", "different", "types", "of", "preparations", "were", "compared", "in", "order", "to", "verify", "the", "conservation", "of", "the", "antigen.", "Nuclear", "suspensions", "prepared", "from", "frozen", "tumor", "fragments", "were", "shown", "to", "produce", "results", "equivalent", "to", "those", "of", "whole", "cell", "preparations", "originating", "from", "fresh", "surgical", "specimens.", "The", "p53", "protein", "was", "detected", "in", "9", "of", "the", "16", "cancers", "with", "pAb", "421", "and", "240", "monoclonal", "antibodies", "(8", "of", "which", "were", "also", "positive", "for", "pAb", "1801", "antibody).", "Four", "additional", "tumors", "were", "considered", "positive", "for", "pAb", "240", "antibody", "alone.", "Overall,", "13/16", "cancer", "specimens", "were", "shown", "to", "present", "immunoreactivity", "for", "pAb", "240", "antibody.", "Topography", "of", "staining", "was", "investigated", "by", "immunohistochemistry", "with", "peroxidase", "methods.", "Eight", "cases", "were", "informative,", "6", "of", "which", "presented", "nuclear", "staining", "compatible", "with", "the", "cytometry", "results.", "There", "was", "one", "discordant", "case", "i.e.", "pAb", "240", "1801", "pAb", "421", ",", "1801,", "240).", "Specific", "immunofluorescent", "staining", "was", "quantified", "by", "dual", "parameter", "(DNA/p53)", "flow", "cytometry.", "Two", "different", "types", "of", "preparations", "were", "compared", "in", "order", "to", "verify", "the", "conservation", "of", "the", "antigen.", "Nuclear", "suspensions", "prepared", "from", "frozen", "tumor", "fragments", "were", "shown", "to", "produce", "results", "equivalent", "to", "those", "of", "whole", "cell", "preparations", "originating", "from", "fresh", "surgical", "specimens.", "The", "p53", "protein", "was", "detected", "in", "9", "of", "the", "16", "cancers", "with", "pAb", "421", "and", "240", "240", ").", "Specific", "immunofluorescent", "staining", "was", "quantified", "by", "dual", "parameter", "(DNA/p53)", "flow", "cytometry.", "Two", "different", "types", "of", "preparations", "were", "compared", "in", "order", "to", "verify", "the", "conservation", "of", "the", "antigen.", "Nuclear", "suspensions", "prepared", "from", "frozen", "tumor", "fragments", "were", "shown", "to", "produce", "results", "equivalent", "to", "those", "of", "whole", "cell", "preparations", "originating", "from", "fresh", "surgical", "specimens.", "The", "p53", "protein", "was", "detected", "in", "9", "of", "the", "16", "cancers", "with", "pAb", "421", " ", "and", "240", "monoclonal", "antibodies", "(8", "of", "which", "were", "also", "positive", "for", "pAb", "1801", "p53", " ", "gene", "have", "been", "shown", "to", "be", "frequent,", "the", "protein", "was", "present", "in", "only", "approximately", "50", "percent", "of", "specimens", "examined.", "However", "only", "one", "monoclonal", "antibody", "recognizing", "an", "epitope", "present", "on", "wild-type", "p53", "had", "been", "used.", "We", "studied", "the", "p53", "expression", "in", "a", "series", "of", "16", "colorectal", "carcinoma", "specimens", "using", "3", "different", "monoclonal", "antibodies", "(pAb", "421,", "1801,", "240).", "Specific", "immunofluorescent", "staining", "was", "quantified", "by", "dual", "parameter", "(DNA/p53)", "flow", "cytometry.", "Two", "different", "types", "of", "preparations", "were", "compared", "in", "order", "to", "verify", "the", "conservation", "of", "the", "antigen.", "Nuclear", "suspensions", "prepared", "from", "frozen", "tumor", "fragments", "were", "shown", "to", "produce", "results", "equivalent", "to", "those", "of", "whole", "cell", "preparations", "originating", "from", "fresh", "surgical", "specimens.", "The", "p53", "protein", "was", "detected", "in", "9", "of", "the", "16", "cancers", "with", "pAb", "421", "and", "240", "monoclonal", "antibodies", "(8", "of", "which", "were", "also", "positive", "for", "pAb", "1801", "antibody).", "Four", "additional", "tumors", "were", "considered", "positive", "for", "pAb", "240", "antibody", "alone.", "Overall,", "13/16", "cancer", "specimens", "were", "shown", "to", "present", "immunoreactivity", "for", "pAb", "240", "p53", " ", "had", "been", "used.", "We", "studied", "the", "p53", " ", "expression", "in", "a", "series", "of", "16", "colorectal", "carcinoma", "specimens", "using", "3", "different", "monoclonal", "antibodies", "(pAb", "421,", "1801,", "240).", "Specific", "immunofluorescent", "staining", "was", "quantified", "by", "dual", "parameter", "(DNA/p53)", "flow", "cytometry.", "Two", "different", "types", "of", "preparations", "were", "compared", "in", "order", "to", "verify", "the", "conservation", "of", "the", "antigen.", "Nuclear", "suspensions", "prepared", "from", "frozen", "tumor", "fragments", "were", "shown", "to", "produce", "results", "equivalent", "to", "those", "of", "whole", "cell", "preparations", "originating", "from", "fresh", "surgical", "specimens.", "The", "p53", "protein", "was", "detected", "in", "9", "of", "the", "16", "cancers", "with", "pAb", "421", "and", "240", "monoclonal", "antibodies", "(8", "of", "which", "were", "also", "positive", "for", "pAb", "1801", "antibody).", "Four", "additional", "tumors", "were", "considered", "positive", "for", "pAb", "240", "antibody", "alone.", "Overall,", "13/16", "cancer", "specimens", "were", "shown", "to", "present", "immunoreactivity", "for", "pAb", "240", "antibody.", "Topography", "of", "staining", "was", "investigated", "by", "immunohistochemistry", "with", "peroxidase", "methods.", "Eight", "cases", "were", "informative,", "6", "of", "which", "presented", "nuclear", "staining", "compatible", "with", "the", "cytometry", "results.", "There", "was", "one", "discordant", "case", "i.e.", "pAb", "240", "antibody", "being", "positive", "on", "cytometry", "and", "entirely", "negative", "on", "immunohistochemistry.", "This", "small", "series", "allowed", "us", "to", "show", "that", "81", "percent", "of", "tumor", "samples", "stained", "with", "monoclonal", "antibody", "pAb", "240,", "considered", "to", "be", "specific", "to", "mutated", "protein,", "and", "that", "some", "tumors", "express", "a", "p53", "protein", "which", "is", "not", "detected", "with", "terminal", "sequence-specific", "antibodies." ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 1, 2, 1, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Evidence is accumulating that the p53 anti-oncogene is a key gene in the genesis of carcinoma in human colon and rectum. Although mutations of the p53 gene have been shown to be frequent, the protein was present in only approximately 50 percent of specimens examined. However only one monoclonal antibody recognizing an epitope present on wild-type p53 had been used. We studied the p53 expression in a series of 16 colorectal carcinoma specimens using 3 different monoclonal antibodies (pAb 421, 1801, 240). Specific immunofluorescent staining was quantified by dual parameter (DNA/p53) flow cytometry. Two different types of preparations were compared in order to verify the conservation of the antigen. Nuclear suspensions prepared from frozen tumor fragments were shown to produce results equivalent to those of whole cell preparations originating from fresh surgical specimens. The p53 protein was detected in 9 of the 16 cancers with pAb 421 and 240 monoclonal antibodies (8 of which were also positive for pAb 1801 antibody). Four additional tumors were considered positive for pAb 240 antibody alone. Overall, 13/16 cancer specimens were shown to present immunoreactivity for pAb 240 antibody. Topography of staining was investigated by immunohistochemistry with peroxidase methods. Eight cases were informative, 6 of which presented nuclear staining compatible with the cytometry results. There was one discordant case i.e. pAb 240 antibody being positive on cytometry and entirely negative on immunohistochemistry. This small series allowed us to show that 81 percent of tumor samples stained with monoclonal antibody pAb 240, considered to be specific to mutated pAb 240 pAb 240 p53 ) flow cytometry. Two different types of preparations were compared in order to verify the conservation of the antigen. Nuclear suspensions prepared from frozen tumor fragments were shown to produce results equivalent to those of whole cell preparations originating from fresh surgical specimens. The p53 protein was detected in 9 of the 16 cancers with pAb 421 and 240 monoclonal antibodies (8 of which were also positive for pAb 1801 antibody). Four additional tumors were considered positive for pAb 240 antibody alone. Overall, 13/16 cancer specimens were shown to present immunoreactivity for pAb 240 antibody. Topography of staining was investigated by immunohistochemistry with peroxidase methods. Eight cases were informative, 6 of which presented nuclear staining compatible with the cytometry results. There was one discordant case i.e. pAb 240 1801 pAb 421 , 1801, 240). Specific immunofluorescent staining was quantified by dual parameter (DNA/p53) flow cytometry. Two different types of preparations were compared in order to verify the conservation of the antigen. Nuclear suspensions prepared from frozen tumor fragments were shown to produce results equivalent to those of whole cell preparations originating from fresh surgical specimens. The p53 protein was detected in 9 of the 16 cancers with pAb 421 and 240 240 ). Specific immunofluorescent staining was quantified by dual parameter (DNA/p53) flow cytometry. Two different types of preparations were compared in order to verify the conservation of the antigen. Nuclear suspensions prepared from frozen tumor fragments were shown to produce results equivalent to those of whole cell preparations originating from fresh surgical specimens. The p53 protein was detected in 9 of the 16 cancers with pAb 421 and 240 monoclonal antibodies (8 of which were also positive for pAb 1801 p53 gene have been shown to be frequent, the protein was present in only approximately 50 percent of specimens examined. However only one monoclonal antibody recognizing an epitope present on wild-type p53 had been used. We studied the p53 expression in a series of 16 colorectal carcinoma specimens using 3 different monoclonal antibodies (pAb 421, 1801, 240). Specific immunofluorescent staining was quantified by dual parameter (DNA/p53) flow cytometry. Two different types of preparations were compared in order to verify the conservation of the antigen. Nuclear suspensions prepared from frozen tumor fragments were shown to produce results equivalent to those of whole cell preparations originating from fresh surgical specimens. The p53 protein was detected in 9 of the 16 cancers with pAb 421 and 240 monoclonal antibodies (8 of which were also positive for pAb 1801 antibody). Four additional tumors were considered positive for pAb 240 antibody alone. Overall, 13/16 cancer specimens were shown to present immunoreactivity for pAb 240 p53 had been used. We studied the p53 expression in a series of 16 colorectal carcinoma specimens using 3 different monoclonal antibodies (pAb 421, 1801, 240). Specific immunofluorescent staining was quantified by dual parameter (DNA/p53) flow cytometry. Two different types of preparations were compared in order to verify the conservation of the antigen. Nuclear suspensions prepared from frozen tumor fragments were shown to produce results equivalent to those of whole cell preparations originating from fresh surgical specimens. The p53 protein was detected in 9 of the 16 cancers with pAb 421 and 240 monoclonal antibodies (8 of which were also positive for pAb 1801 antibody). Four additional tumors were considered positive for pAb 240 antibody alone. Overall, 13/16 cancer specimens were shown to present immunoreactivity for pAb 240 antibody. Topography of staining was investigated by immunohistochemistry with peroxidase methods. Eight cases were informative, 6 of which presented nuclear staining compatible with the cytometry results. There was one discordant case i.e. pAb 240 antibody being positive on cytometry and entirely negative on immunohistochemistry. This small series allowed us to show that 81 percent of tumor samples stained with monoclonal antibody pAb 240, considered to be specific to mutated protein, and that some tumors express a p53 protein which is not detected with terminal sequence-specific antibodies.
[ 2, 3095, 1977, 16040, 1988, 1920, 5105, 2246, 17, 13738, 1977, 43, 3834, 2359, 1922, 1920, 25309, 1927, 5373, 1922, 2616, 4120, 1930, 19773, 18, 2876, 3527, 1927, 1920, 5105, 2359, 2162, 2252, 2522, 1942, 1998, 6439, 16, 1920, 2213, 1982, 2481, 1922, 2444, 3993, 2761, 3564, 1927, 5864, 3572, 18, 2406, 2444, 2340, 7172, 3533, 15667, 1925, 10095, 2481, 1990, 3576, 17, 2601, 5105, 2430, 2252, 2251, 18, 2038, 3942, 1920, 5105, 2294, 1922, 43, 4696, 1927, 2641, 7820, 5373, 5864, 2193, 23, 2413, 7172, 3788, 12, 16995, 28414, 16, 8585, 1009, 16, 12075, 13, 18, 2487, 22205, 4166, 1982, 6395, 2007, 7064, 5817, 12, 2678, 19, 5105, 13, 3426, 7377, 18, 2288, 2413, 3584, 1927, 9815, 1985, 2452, 1922, 3238, 1942, 10491, 1920, 9365, 1927, 1920, 4730, 18, 4254, 14532, 4649, 2037, 8197, 2798, 6535, 1985, 2522, 1942, 5074, 2274, 6582, 1942, 2690, 1927, 4292, 2024, 9815, 14391, 2037, 6427, 4548, 5864, 18, 1920, 5105, 2213, 1982, 3330, 1922, 29, 1927, 1920, 2641, 5717, 1956, 16995, 28414, 1930, 12075, 7172, 3788, 12, 28, 1927, 2154, 1985, 2222, 2843, 1958, 16995, 8585, 1009, 3533, 13, 18, 3006, 3281, 3861, 1985, 3311, 2843, 1958, 16995, 12075, 3533, 4298, 18, 3399, 16, 2590, 19, 2641, 2539, 5864, 1985, 2522, 1942, 2481, 11522, 1958, 16995, 12075, 3533, 18, 18198, 1927, 4166, 1982, 3845, 2007, 9101, 1956, 9433, 2860, 18, 5066, 2919, 1985, 12840, 16, 26, 1927, 2154, 3549, 4254, 4166, 11290, 1956, 1920, 7377, 2274, 18, 2276, 1982, 2340, 20246, 3087, 51, 18, 47, 18, 16995, 12075, 3533, 3301, 2843, 1990, 7377, 1930, 11668, 3136, 1990, 9101, 18, 2052, 2858, 4696, 5563, 2022, 1942, 2146, 1988, 6206, 3564, 1927, 2798, 2785, 5193, 1956, 7172, 3533, 16995, 12075, 16, 3311, 1942, 1998, 2487, 1942, 8336, 16995, 12075, 16995, 12075, 5105, 13, 3426, 7377, 18, 2288, 2413, 3584, 1927, 9815, 1985, 2452, 1922, 3238, 1942, 10491, 1920, 9365, 1927, 1920, 4730, 18, 4254, 14532, 4649, 2037, 8197, 2798, 6535, 1985, 2522, 1942, 5074, 2274, 6582, 1942, 2690, 1927, 4292, 2024, 9815, 14391, 2037, 6427, 4548, 5864, 18, 1920, 5105, 2213, 1982, 3330, 1922, 29, 1927, 1920, 2641, 5717, 1956, 16995, 28414, 1930, 12075, 7172, 3788, 12, 28, 1927, 2154, 1985, 2222, 2843, 1958, 16995, 8585, 1009, 3533, 13, 18, 3006, 3281, 3861, 1985, 3311, 2843, 1958, 16995, 12075, 3533, 4298, 18, 3399, 16, 2590, 19, 2641, 2539, 5864, 1985, 2522, 1942, 2481, 11522, 1958, 16995, 12075, 3533, 18, 18198, 1927, 4166, 1982, 3845, 2007, 9101, 1956, 9433, 2860, 18, 5066, 2919, 1985, 12840, 16, 26, 1927, 2154, 3549, 4254, 4166, 11290, 1956, 1920, 7377, 2274, 18, 2276, 1982, 2340, 20246, 3087, 51, 18, 47, 18, 16995, 12075, 8585, 1009, 16995, 28414, 16, 8585, 1009, 16, 12075, 13, 18, 2487, 22205, 4166, 1982, 6395, 2007, 7064, 5817, 12, 2678, 19, 5105, 13, 3426, 7377, 18, 2288, 2413, 3584, 1927, 9815, 1985, 2452, 1922, 3238, 1942, 10491, 1920, 9365, 1927, 1920, 4730, 18, 4254, 14532, 4649, 2037, 8197, 2798, 6535, 1985, 2522, 1942, 5074, 2274, 6582, 1942, 2690, 1927, 4292, 2024, 9815, 14391, 2037, 6427, 4548, 5864, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 1, 2, 1, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 2, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
24568449
[ "PubMed,", "EMBASE,", "CNKI", "databases", "were", "searched", "with", "the", "last", "search", "updated", "on", "November", "5,", "2013.", "For", "miR-196a2", "rs11614913,", "a", "significantly", "decreased", "risk", "of", "CRC", "development", "was", "observed", "under", "three", "genetic", "models", "(dominant", "model:", "OR", "=", "0.848,", "95%CI:", "0.735-0.979,", "P", "=", "0.025;", "recessive", "model:", "OR", "=", "0.838,", "95%CI:", "0.721-0.974,", "P", "=", "0.021;", "homozygous", "model:", "OR", "=", "0.754,", "95%CI:", "0.627-0.907,", "P", "=", "0.003).", "In", "the", "subgroup", "analyses,", "miR-196a2*T", "variant", "was", "associated", "with", "a", "significantly", "decreased", "susceptibility", "of", "CRC", "(allele", "model:", "OR", "=", "0.839,", "95%CI:", "0.749-0.940,", "P", "=", "0.000;", "dominant", "model:", "OR", "=", "0.770,", "95%CI:", "0.653-0.980,", "P", "=", "0.002;", "recessive", "model:", "OR", "=", "0.802,", "95%CI:", "0.685-0.939,", "P", "=", "0.006;", "homozygous", "model:", "OR", "=", "0.695,", "95%CI:", "0.570-0.847,", "P", "=", "0.000).", "As", "for", "miR-149", "rs2292832,", "the", "two", "genetic", "models", "(recessive", "model:", "OR", "=", "1.199,", "95%", "CI", "1.028-1.398,", "P", "=", "0.021;", "heterozygous", "model:", "OR", "=", "1.226,", "95%", "CI", "1.039-1.447,", "P", "=", "0.013)", "demonstrated", "increased", "susceptibility", "to", "CRC.", "On", "subgroup", "analysis,", "significantly", "increased", "susceptibility", "of", "CRC", "was", "found", "in", "the", "genetic", "models", "(recessive", "model:", "OR", "=", "1.180,", "95%", "CI", "1.008-1.382,", "P", "=", "0.040;", "heterozygous", "model:", "OR", "=", "1.202,", "95%", "CI", "1.013-1.425,", "P", "=", "0.013)", "in", "the", "Asian", "group." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
PubMed, EMBASE, CNKI databases were searched with the last search updated on November 5, 2013. For miR-196a2 rs11614913, a significantly decreased risk of CRC development was observed under three genetic models (dominant model: OR = 0.848, 95%CI: 0.735-0.979, P = 0.025; recessive model: OR = 0.838, 95%CI: 0.721-0.974, P = 0.021; homozygous model: OR = 0.754, 95%CI: 0.627-0.907, P = 0.003). In the subgroup analyses, miR-196a2*T variant was associated with a significantly decreased susceptibility of CRC (allele model: OR = 0.839, 95%CI: 0.749-0.940, P = 0.000; dominant model: OR = 0.770, 95%CI: 0.653-0.980, P = 0.002; recessive model: OR = 0.802, 95%CI: 0.685-0.939, P = 0.006; homozygous model: OR = 0.695, 95%CI: 0.570-0.847, P = 0.000). As for miR-149 rs2292832, the two genetic models (recessive model: OR = 1.199, 95% CI 1.028-1.398, P = 0.021; heterozygous model: OR = 1.226, 95% CI 1.039-1.447, P = 0.013) demonstrated increased susceptibility to CRC. On subgroup analysis, significantly increased susceptibility of CRC was found in the genetic models (recessive model: OR = 1.180, 95% CI 1.008-1.382, P = 0.040; heterozygous model: OR = 1.202, 95% CI 1.013-1.425, P = 0.013) in the Asian group.
[ 2, 13093, 16, 18319, 16, 5940, 7369, 8506, 1985, 11415, 1956, 1920, 4691, 4603, 13236, 1990, 12832, 25, 16, 3871, 18, 1958, 3138, 17, 16841, 8398, 4366, 12618, 22987, 3633, 16, 43, 2567, 3261, 2565, 1927, 8223, 2740, 1982, 2528, 2441, 2559, 3299, 3130, 12, 6379, 2322, 30, 2014, 33, 20, 18, 5686, 1025, 16, 3002, 9, 3371, 30, 20, 18, 5356, 1015, 17, 20, 18, 5749, 1026, 16, 58, 33, 20, 18, 15008, 31, 13992, 2322, 30, 2014, 33, 20, 18, 5893, 1025, 16, 3002, 9, 3371, 30, 20, 18, 4395, 1009, 17, 20, 18, 5749, 1006, 16, 58, 33, 20, 18, 21745, 31, 9419, 2322, 30, 2014, 33, 20, 18, 4089, 1006, 16, 3002, 9, 3371, 30, 20, 18, 5374, 1027, 17, 20, 18, 3865, 1027, 16, 58, 33, 20, 18, 10438, 13, 18, 1922, 1920, 6200, 3247, 16, 3138, 17, 16841, 8398, 14, 62, 6031, 1982, 2458, 1956, 43, 2567, 3261, 6461, 1927, 8223, 12, 5465, 2322, 30, 2014, 33, 20, 18, 5893, 1026, 16, 3002, 9, 3371, 30, 20, 18, 5446, 1026, 17, 20, 18, 5650, 1008, 16, 58, 33, 20, 18, 3240, 31, 6379, 2322, 30, 2014, 33, 20, 18, 28791, 16, 3002, 9, 3371, 30, 20, 18, 4459, 1010, 17, 20, 18, 28399, 16, 58, 33, 20, 18, 9299, 31, 13992, 2322, 30, 2014, 33, 20, 18, 3729, 1028, 16, 3002, 9, 3371, 30, 20, 18, 5117, 1015, 17, 20, 18, 6156, 1026, 16, 58, 33, 20, 18, 12791, 31, 9419, 2322, 30, 2014, 33, 20, 18, 5349, 1015, 16, 3002, 9, 3371, 30, 20, 18, 20928, 17, 20, 18, 5686, 1027, 16, 58, 33, 20, 18, 3240, 13, 18, 1966, 1958, 3138, 17, 14094, 4366, 24570, 4839, 6763, 16, 1920, 2288, 3299, 3130, 12, 13992, 2322, 30, 2014, 33, 21, 18, 2717, 16, 3002, 9, 3371, 21, 18, 20214, 17, 21, 18, 26529, 16, 58, 33, 20, 18, 21745, 31, 9589, 2322, 30, 2014, 33, 21, 18, 19637, 16, 3002, 9, 3371, 21, 18, 24302, 17, 21, 18, 29146, 16, 58, 33, 20, 18, 17695, 13, 3161, 2502, 6461, 1942, 8223, 18, 1990, 6200, 2333, 16, 2567, 2502, 6461, 1927, 8223, 1982, 2435, 1922, 1920, 3299, 3130, 12, 13992, 2322, 30, 2014, 33, 21, 18, 8585, 16, 3002, 9, 3371, 21, 18, 13587, 17, 21, 18, 27991, 16, 58, 33, 20, 18, 22902, 31, 9589, 2322, 30, 2014, 33, 21, 18, 17401, 16, 3002, 9, 3371, 21, 18, 17695, 17, 21, 18, 24592, 16, 58, 33, 20, 18, 17695, 13, 1922, 1920, 9686, 2210, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
23603433
[ "Specific", "patterns", "of", "genomic", "aberrations", "have", "been", "associated", "with", "different", "types", "of", "malignancies.", "In", "colorectal", "cancer,", "losses", "of", "chromosome", "arm", "8p", "and", "gains", "of", "chromosome", "arm", "8q", "are", "among", "the", "most", "common", "chromosomal", "rearrangements,", "suggesting", "that", "the", "centromeric", "portion", "of", "chromosome", "8", " ", "is", "particularly", "sensitive", "to", "breakage.", "Genomic", "alterations", "frequently", "occur", "in", "the", "early", "stages", "of", "tumorigenesis", "at", "specific", "genomic", "regions", "known", "as", "common", "fragile", "sites", "(cFSs).", "CFSs", "represent", "parts", "of", "the", "normal", "chromosome", "structure", "that", "are", "prone", "to", "breakage", "under", "replication", "stress.", "In", "this", "study,", "we", "identified", "the", "genomic", "location", "of", "FRA8I", ",", "spanning", "530", "kb", "at", "8q11.21", " ", "and", "assessed", "the", "composition", "of", "the", "fragile", "DNA", "sequence.", "FRA8I", " ", "encompasses", "KIAA0146,", "a", "large", "protein-coding", "gene", "with", "yet", "unknown", "function,", "as", "well", "as", "CEBPD", "KIAA0146", ",", "a", "large", "protein-coding", "gene", "with", "yet", "unknown", "function,", "as", "well", "as", "CEBPD", "and", "part", "of", "PRKDC,", "two", "genes", "encoding", "proteins", "involved", "in", "tumorigenesis", "in", "a", "variety", "of", "cancers.", "We", "show", "that", "FRA8I", "PRKDC", ",", "two", "genes", "encoding", "proteins", "involved", "in", "tumorigenesis", "in", "a", "variety", "of", "cancers.", "We", "show", "that", "FRA8I", "is", "unstable", "in", "lymphocytes", "and", "epithelial", "cells,", "displaying", "similar", "expression", "rates.", "We", "examined", "copy", "number", "alteration", "patterns", "within", "FRA8I", "in", "a", "panel", "of", "25", "colorectal", "cancer", "cell", "lines", "and", "surveyed", "publically", "available", "profiles", "of", "56", "additional", "colorectal", "cancer", "cell", "lines.", "Combining", "these", "data", "shows", "that", "focal", "recombination", "events", "disrupt", "the", "genomic", "integrity", "of", "KIAA0146", " ", "and", "neighboring", "cFS", "genes", "in", "12.3%", "of", "colorectal", "cancer", "cell", "lines.", "Moreover,", "data", "analysis", "revealed", "evidence", "that", "KIAA0146", "is", "a", "translocation", "partner", "of", "the", "immunoglobulin", "heavy", "chain", "gene", "in", "recurrent", "t(8;14)(q11;q32)", "translocations", " ", "in", "a", "subset", "of", "patients", "with", "B-cell", "precursor", "acute", "lymphoblastic", "leukemia.", "Our", "data", "molecularly", "describe", "a", "region", "of", "enhanced", "chromosomal", "instability", "KIAA0146", "common", "fragile", "sites", " ", "(cFSs).", "CFSs", "represent", "parts", "of", "the", "normal", "chromosome", "structure", "that", "are", "prone", "to", "breakage", "under", "replication", "stress.", "In", "this", "study,", "we", "identified", "the", "genomic", "location", "of", "FRA8I,", "spanning", "530", "kb", "at", "8q11.21", "and", "assessed", "the", "composition", "of", "the", "fragile", "DNA", "sequence.", "FRA8I", "encompasses", "KIAA0146,", "a", "large", "protein-coding", "gene", "with", "yet", "unknown", "function,", "as", "well", "as", "CEBPD", "and", "part", "of", "PRKDC,", "two", "genes", "encoding", "proteins", "involved", "in", "tumorigenesis", "in", "a", "variety", "of", "cancers.", "We", "show", "that", "FRA8I", "is", "unstable", "in", "lymphocytes", "and", "epithelial", "cells,", "displaying", "similar", "expression", "rates.", "We", "examined", "copy", "number", "alteration", "patterns", "within", "FRA8I", "centromeric", " ", "portion", "of", "chromosome", "8", "is", "particularly", "sensitive", "to", "breakage.", "Genomic", "alterations", "frequently", "occur", "in", "the", "early", "stages", "of", "tumorigenesis", "at", "specific", "genomic", "regions", "known", "as", "common", "fragile", "sites", "(cFSs).", "CFSs", "represent", "parts", "of", "the", "normal", "chromosome", "structure", "that", "are", "prone", "to", "breakage", "under", "replication", "stress.", "In", "this", "study,", "we", "identified", "the", "genomic", "location", "of", "FRA8I,", "spanning", "530", "kb", "at", "8q11.21", "and", "assessed", "the", "composition", "of", "the", "fragile", "DNA", "sequence.", "FRA8I", "encompasses", "KIAA0146,", "a", "large", "protein-coding", "gene", "with", "yet", "unknown", "function,", "as", "well", "as", "CEBPD", "and", "part", "of", "PRKDC,", "two", "genes", "encoding", "proteins", "involved", "in", "tumorigenesis", "in", "a", "variety", "of", "cancers.", "We", "show", "that", "FRA8I", "is", "unstable", "in", "lymphocytes", "and", "epithelial", "cells,", "displaying", "similar", "expression", "rates.", "We", "examined", "copy", "number", "alteration", "patterns", "within", "FRA8I", "in", "a", "panel", "of", "25", "colorectal", "cancer", "cell", "lines", "and", "surveyed", "publically", "available", "profiles", "of", "56", "additional", "colorectal", "cancer", "cell", "lines.", "Combining", "these", "data", "shows", "that", "focal", "recombination", "events", "disrupt", "the", "genomic", "integrity", "of", "KIAA0146", "and", "neighboring", "cFS", "genes", "in", "12.3%", "of", "colorectal", "cancer", "cell", "lines.", "Moreover,", "data", "analysis", "revealed", "evidence", "that", "KIAA0146", "is", "a", "translocation", "partner", "of", "the", "immunoglobulin", "heavy", "chain", "gene", "in", "recurrent", "t(8;14)(q11;q32)", "translocations", "in", "a", "subset", "of", "patients", "with", "B-cell", "precursor", "acute", "lymphoblastic", "leukemia.", "Our", "data", "molecularly", "describe", "a", "region", "of", "enhanced", "chromosomal", "instability", "in", "the", "human", "genome", "and", "point", "to", "a", "role", "of", "the", "KIAA0146", "cFSs", "KIAA0146", ",", "CEBPD", "and", "PRKDC", "genes", "in", "colorectal", "cancer." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 1, 7, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 7, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
Specific patterns of genomic aberrations have been associated with different types of malignancies. In colorectal cancer, losses of chromosome arm 8p and gains of chromosome arm 8q are among the most common chromosomal rearrangements, suggesting that the centromeric portion of chromosome 8 is particularly sensitive to breakage. Genomic alterations frequently occur in the early stages of tumorigenesis at specific genomic regions known as common fragile sites (cFSs). CFSs represent parts of the normal chromosome structure that are prone to breakage under replication stress. In this study, we identified the genomic location of FRA8I , spanning 530 kb at 8q11.21 and assessed the composition of the fragile DNA sequence. FRA8I encompasses KIAA0146, a large protein-coding gene with yet unknown function, as well as CEBPD KIAA0146 , a large protein-coding gene with yet unknown function, as well as CEBPD and part of PRKDC, two genes encoding proteins involved in tumorigenesis in a variety of cancers. We show that FRA8I PRKDC , two genes encoding proteins involved in tumorigenesis in a variety of cancers. We show that FRA8I is unstable in lymphocytes and epithelial cells, displaying similar expression rates. We examined copy number alteration patterns within FRA8I in a panel of 25 colorectal cancer cell lines and surveyed publically available profiles of 56 additional colorectal cancer cell lines. Combining these data shows that focal recombination events disrupt the genomic integrity of KIAA0146 and neighboring cFS genes in 12.3% of colorectal cancer cell lines. Moreover, data analysis revealed evidence that KIAA0146 is a translocation partner of the immunoglobulin heavy chain gene in recurrent t(8;14)(q11;q32) translocations in a subset of patients with B-cell precursor acute lymphoblastic leukemia. Our data molecularly describe a region of enhanced chromosomal instability KIAA0146 common fragile sites (cFSs). CFSs represent parts of the normal chromosome structure that are prone to breakage under replication stress. In this study, we identified the genomic location of FRA8I, spanning 530 kb at 8q11.21 and assessed the composition of the fragile DNA sequence. FRA8I encompasses KIAA0146, a large protein-coding gene with yet unknown function, as well as CEBPD and part of PRKDC, two genes encoding proteins involved in tumorigenesis in a variety of cancers. We show that FRA8I is unstable in lymphocytes and epithelial cells, displaying similar expression rates. We examined copy number alteration patterns within FRA8I centromeric portion of chromosome 8 is particularly sensitive to breakage. Genomic alterations frequently occur in the early stages of tumorigenesis at specific genomic regions known as common fragile sites (cFSs). CFSs represent parts of the normal chromosome structure that are prone to breakage under replication stress. In this study, we identified the genomic location of FRA8I, spanning 530 kb at 8q11.21 and assessed the composition of the fragile DNA sequence. FRA8I encompasses KIAA0146, a large protein-coding gene with yet unknown function, as well as CEBPD and part of PRKDC, two genes encoding proteins involved in tumorigenesis in a variety of cancers. We show that FRA8I is unstable in lymphocytes and epithelial cells, displaying similar expression rates. We examined copy number alteration patterns within FRA8I in a panel of 25 colorectal cancer cell lines and surveyed publically available profiles of 56 additional colorectal cancer cell lines. Combining these data shows that focal recombination events disrupt the genomic integrity of KIAA0146 and neighboring cFS genes in 12.3% of colorectal cancer cell lines. Moreover, data analysis revealed evidence that KIAA0146 is a translocation partner of the immunoglobulin heavy chain gene in recurrent t(8;14)(q11;q32) translocations in a subset of patients with B-cell precursor acute lymphoblastic leukemia. Our data molecularly describe a region of enhanced chromosomal instability in the human genome and point to a role of the KIAA0146 cFSs KIAA0146 , CEBPD and PRKDC genes in colorectal cancer.
[ 2, 2487, 4147, 1927, 4935, 16303, 2162, 2252, 2458, 1956, 2413, 3584, 1927, 10672, 18, 1922, 7820, 2539, 16, 11783, 1927, 5597, 6011, 28, 1034, 1930, 13241, 1927, 5597, 6011, 28, 1055, 2032, 2706, 1920, 2501, 3059, 9220, 13955, 16, 3783, 1988, 1920, 25790, 7717, 1927, 5597, 28, 1977, 4443, 4532, 1942, 25816, 18, 4935, 5996, 5467, 4704, 1922, 1920, 3120, 5143, 1927, 11472, 2019, 2487, 4935, 3451, 3171, 1966, 3059, 19734, 3402, 12, 14653, 1036, 13, 18, 14653, 1036, 3015, 7516, 1927, 1920, 2791, 5597, 3170, 1988, 2032, 10424, 1942, 25816, 2441, 5158, 3071, 18, 1922, 2052, 2161, 16, 2038, 2899, 1920, 4935, 5185, 1927, 23228, 1025, 1033, 16, 13346, 21157, 6633, 2019, 28, 23931, 18, 2900, 1930, 3683, 1920, 5128, 1927, 1920, 19734, 2678, 3244, 18, 23228, 1025, 1033, 21569, 8191, 5025, 6924, 7772, 16, 43, 3103, 2213, 17, 5804, 2359, 1956, 4898, 5435, 2347, 16, 1966, 2486, 1966, 5827, 3846, 1007, 8191, 5025, 6924, 7772, 16, 43, 3103, 2213, 17, 5804, 2359, 1956, 4898, 5435, 2347, 16, 1966, 2486, 1966, 5827, 3846, 1007, 1930, 3131, 1927, 22615, 11385, 16, 2288, 2628, 5797, 2697, 3286, 1922, 11472, 1922, 43, 5386, 1927, 5717, 18, 2038, 2146, 1988, 23228, 1025, 1033, 22615, 11385, 16, 2288, 2628, 5797, 2697, 3286, 1922, 11472, 1922, 43, 5386, 1927, 5717, 18, 2038, 2146, 1988, 23228, 1025, 1033, 1977, 11976, 1922, 7257, 1930, 4944, 2094, 16, 13867, 2551, 2294, 3389, 18, 2038, 3572, 6983, 2529, 10076, 4147, 2651, 23228, 1025, 1033, 1922, 43, 4812, 1927, 2637, 7820, 2539, 2024, 3557, 1930, 15544, 4462, 2169, 3322, 5554, 1927, 4489, 3281, 7820, 2539, 2024, 3557, 18, 9138, 2144, 2230, 3661, 1988, 8083, 7827, 3916, 12512, 1920, 4935, 7996, 1927, 8191, 5025, 6924, 7772, 1930, 12260, 14653, 2628, 1922, 2369, 18, 23, 9, 1927, 7820, 2539, 2024, 3557, 18, 3950, 16, 2230, 2333, 3404, 3095, 1988, 8191, 5025, 6924, 7772, 1977, 43, 7849, 8240, 1927, 1920, 11837, 7881, 4659, 2359, 1922, 7457, 62, 12, 28, 31, 2607, 13, 12, 22027, 1009, 31, 25760, 1028, 13, 22436, 1922, 43, 6728, 1927, 2132, 1956, 44, 17, 2024, 7897, 3939, 24403, 8111, 18, 2342, 2230, 26391, 5993, 43, 3031, 1927, 4256, 9220, 9557, 8191, 5025, 6924, 7772, 3059, 19734, 3402, 12, 14653, 1036, 13, 18, 14653, 1036, 3015, 7516, 1927, 1920, 2791, 5597, 3170, 1988, 2032, 10424, 1942, 25816, 2441, 5158, 3071, 18, 1922, 2052, 2161, 16, 2038, 2899, 1920, 4935, 5185, 1927, 23228, 1025, 1033, 16, 13346, 21157, 6633, 2019, 28, 23931, 18, 2900, 1930, 3683, 1920, 5128, 1927, 1920, 19734, 2678, 3244, 18, 23228, 1025, 1033, 21569, 8191, 5025, 6924, 7772, 16, 43, 3103, 2213, 17, 5804, 2359, 1956, 4898, 5435, 2347, 16, 1966, 2486, 1966, 5827, 3846, 1007, 1930, 3131, 1927, 22615, 11385, 16, 2288, 2628, 5797, 2697, 3286, 1922, 11472, 1922, 43, 5386, 1927, 5717, 18, 2038, 2146, 1988, 23228, 1025, 1033, 1977, 11976, 1922, 7257, 1930, 4944, 2094, 16, 13867, 2551, 2294, 3389, 18, 2038, 3572, 6983, 2529, 10076, 4147, 2651, 23228, 1025, 1033, 25790, 7717, 1927, 5597, 28, 1977, 4443, 4532, 1942, 25816, 18, 4935, 5996, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 0, 0, 0, 0, 0, 7, 8, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 1, 2, 2, 2, 7, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 7, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
27070770
[ "Molecular", "genetic", "testing", "of", "the", "genes", "associated", "with", "FAP", "and", "Peutz-Jeghers", "syndromes", "makes", "it", "possible", "to", "timely", "recognize", "family", "members", "at", "high", "risk,", "to", "plan", "therapeutic", "strategy", "and", "to", "affect", "the", "course", "of", "a", "disease.", "The", "joint", "participation", "of", "pediatricians,", "proctologists,", "oncologists,", "morphologists,", "geneticists,", "and", "molecular", "biologists", "is", "essential", "to", "timely", "recognize", "the", "carriers", "of", "the", "syndromes", "and", "a", "better", "prognosis", "in", "these", "patients." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Molecular genetic testing of the genes associated with FAP and Peutz-Jeghers syndromes makes it possible to timely recognize family members at high risk, to plan therapeutic strategy and to affect the course of a disease. The joint participation of pediatricians, proctologists, oncologists, morphologists, geneticists, and molecular biologists is essential to timely recognize the carriers of the syndromes and a better prognosis in these patients.
[ 2, 3272, 3299, 4213, 1927, 1920, 2628, 2458, 1956, 20592, 1930, 2737, 24793, 17, 8988, 2509, 2045, 12688, 7645, 2176, 3216, 1942, 14918, 9967, 3416, 4678, 2019, 2149, 2565, 16, 1942, 4720, 4272, 4884, 1930, 1942, 4081, 1920, 4914, 1927, 43, 2573, 18, 1920, 6047, 7204, 1927, 7460, 9813, 16, 9823, 4575, 22284, 3535, 16, 26757, 16, 3901, 8031, 16, 3299, 3535, 16, 1930, 3272, 29947, 1977, 4415, 1942, 14918, 9967, 1920, 8974, 1927, 1920, 12688, 1930, 43, 3807, 6573, 1922, 2144, 2132, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
12702972
[ "Coprocytobiology:", "on", "the", "nature", "of", "cellular", "elements", "from", "stools", "in", "the", "pathophysiology", "of", "colonic", "disease." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Coprocytobiology: on the nature of cellular elements from stools in the pathophysiology of colonic disease.
[ 2, 3725, 4104, 2355, 28341, 30, 1990, 1920, 4899, 1927, 3689, 5362, 2037, 14839, 1036, 1922, 1920, 11985, 1927, 12401, 2573, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
12534642
[ "Several", "single", "nucleotide", "polymorphisms", "(SNPs)", "of", "the", "cytochrome", "P450", "enzyme", "1A2", "gene", "(CYP1A2)", "have", "been", "reported.", "Here,", "frequencies,", "linkage", "disequilibrium", "and", "phenotypic", "consequences", "of", "six", "SNPs", "are", "described." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Several single nucleotide polymorphisms (SNPs) of the cytochrome P450 enzyme 1A2 gene (CYP1A2) have been reported. Here, frequencies, linkage disequilibrium and phenotypic consequences of six SNPs are described.
[ 2, 2980, 2957, 5489, 8321, 12, 6084, 13, 1927, 1920, 9387, 12088, 4113, 5123, 1028, 2359, 12, 6120, 23750, 13, 2162, 2252, 2568, 18, 3410, 16, 6458, 16, 8611, 19264, 1930, 8189, 7080, 1927, 3798, 6084, 2032, 2910, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
27070770
[ "The", "authors", "give", "the", "results", "of", "their", "examination", "and", "follow-up", "of", "children", "with", "FAP", "and", "Peutz-Jeghers", "hamartoma-polypous", "syndrome.", "In", "addition,", "current", "data", "from", "PubMed,", "Medline", "(including", "reviews,", "original", "articles", "and", "case", "reports)", "were", "used." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The authors give the results of their examination and follow-up of children with FAP and Peutz-Jeghers hamartoma-polypous syndrome. In addition, current data from PubMed, Medline (including reviews, original articles and case reports) were used.
[ 2, 1920, 3875, 7031, 1920, 2274, 1927, 2310, 4981, 1930, 2396, 17, 2353, 1927, 3069, 1956, 20592, 1930, 2737, 24793, 17, 8988, 2509, 2045, 8616, 5263, 2954, 17, 6240, 2080, 4741, 18, 1922, 2459, 16, 3214, 2230, 2037, 13093, 16, 15406, 12, 2710, 8617, 16, 5538, 7670, 1930, 3087, 4710, 13, 1985, 2251, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
24225759
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
14734469
[ "We", "analyzed", "BRAF", "mutations", "in", "26", "colorectal", "cancer", "cell", "lines,", "80", "sporadic", "colorectal", "cancers,", "and", "20", "tumors", "from", "HNPCC", "patients", "by", "DNA", "sequencing", "and", "sequence-specific", "PCR.", "The", "methylation", "status", "of", "the", "hMLH1", "gene", "was", "measured", "by", "either", "sequencing", "or", "restriction", "enzyme", "digestion", "after", "NaHSO(3)", "treatment." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We analyzed BRAF mutations in 26 colorectal cancer cell lines, 80 sporadic colorectal cancers, and 20 tumors from HNPCC patients by DNA sequencing and sequence-specific PCR. The methylation status of the hMLH1 gene was measured by either sequencing or restriction enzyme digestion after NaHSO(3) treatment.
[ 2, 2038, 3265, 11346, 3527, 1922, 3179, 7820, 2539, 2024, 3557, 16, 3729, 13088, 7820, 5717, 16, 1930, 2036, 3861, 2037, 9888, 7693, 1030, 2132, 2007, 2678, 4754, 1930, 3244, 17, 2487, 3343, 18, 1920, 5547, 3642, 1927, 1920, 5833, 1024, 8600, 2359, 1982, 3045, 2007, 3108, 4754, 2014, 7587, 4113, 9379, 2256, 18405, 2204, 12, 23, 13, 2311, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
24576032
[ "The", "College", "of", "American", "Pathologists", "surveys", "are", "the", "largest", "laboratory", "peer", "comparison", "programs", "in", "the", "world.", "These", "programs", "allow", "laboratories", "to", "regularly", "evaluate", "their", "performance", "and", "improve", "the", "accuracy", "of", "the", "patient", "test", "results", "they", "provide.", "Proficiency", "testing", "is", "offered", "twice", "a", "year", "to", "laboratories", "performing", "microsatellite", "instability", " ", "testing.", "These", "surveys", "are", "designed", "to", "emulate", "clinical", "practice,", "and", "some", "surveys", "have", "more", "challenging", "cases", "to", "encourage", "the", "refinement", "of", "laboratory", "practices." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The College of American Pathologists surveys are the largest laboratory peer comparison programs in the world. These programs allow laboratories to regularly evaluate their performance and improve the accuracy of the patient test results they provide. Proficiency testing is offered twice a year to laboratories performing microsatellite instability testing. These surveys are designed to emulate clinical practice, and some surveys have more challenging cases to encourage the refinement of laboratory practices.
[ 2, 1920, 8002, 1927, 5339, 20608, 9293, 2032, 1920, 7585, 4542, 9561, 3723, 6144, 1922, 1920, 4867, 18, 2144, 6144, 3235, 7710, 1942, 13487, 4323, 2310, 3604, 1930, 3326, 1920, 4923, 1927, 1920, 2774, 2648, 2274, 2611, 3394, 18, 23215, 4213, 1977, 10318, 6470, 43, 2476, 1942, 7710, 8219, 16069, 9557, 4213, 18, 2144, 9293, 2032, 4609, 1942, 2391, 4056, 2535, 4695, 16, 1930, 2673, 9293, 2162, 2253, 8764, 2919, 1942, 14549, 1920, 14040, 1927, 4542, 7300, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
16396368
[]
[]
[ 2, 3 ]
[ 0, 0 ]
[ 1, 1 ]
[ -100, -100 ]
22545919
[ "Two", "SNPs", "in", "the", "3'", "untranslated", "region", "of", "UQCRB", "(complex", "III),", "rs7836698", "and", "rs10504961", ",", "were", "associated", "with", "overall", "survival", "(HR", "=", "0.52,", "95%", "CI", "0.32-0.85", "and", "HR", "=", "0.64,", "95%", "CI", "0.42-0.99,", "for", "TT", "carriers).", "These", "associations", "were", "restricted", "to", "the", "group", "of", "patients", "with", "cancer", "located", "in", "the", "colon", "(HR", "=", "0.42,", "95%", "CI", "0.22-0.82", "and", "HR", "=", "0.46,", "95%", "CI", "0.25-0.83).", "Multivariate", "analysis", "indicated", "that", "both", "markers", "might", "act", "as", "independent", "prognostic", "markers.", "Additionally,", "the", "TT", "carriers", "were", "~2", "times", "more", "likely", "to", "develop", "tumours", "in", "the", "colon", "than", "in", "the", "rectum.", "Two", "SNPs", "in", "COX6B1", " ", "(complex", "IV)", "were", "associated", "with", "lymph", "node", "metastasis", "in", "a", "dominant", "model", "(rs6510502,", "OR", "=", "1.75,", "95%", "CI", "1.20-2.57;", "rs10420252", "rs6510502", ",", "OR", "=", "1.75,", "95%", "CI", "1.20-2.57;", "rs10420252,", "OR", "=", "1.68,", "95%", "CI", "1.11-2.53);", "rs6510502", "Polymorphisms", " ", "in", "the", "mitochondrial", "oxidative", "phosphorylation", "chain", "genes", "as", "prognostic", "markers", "for", "colorectal", "cancer.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 11, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Two SNPs in the 3' untranslated region of UQCRB (complex III), rs7836698 and rs10504961 , were associated with overall survival (HR = 0.52, 95% CI 0.32-0.85 and HR = 0.64, 95% CI 0.42-0.99, for TT carriers). These associations were restricted to the group of patients with cancer located in the colon (HR = 0.42, 95% CI 0.22-0.82 and HR = 0.46, 95% CI 0.25-0.83). Multivariate analysis indicated that both markers might act as independent prognostic markers. Additionally, the TT carriers were ~2 times more likely to develop tumours in the colon than in the rectum. Two SNPs in COX6B1 (complex IV) were associated with lymph node metastasis in a dominant model (rs6510502, OR = 1.75, 95% CI 1.20-2.57; rs10420252 rs6510502 , OR = 1.75, 95% CI 1.20-2.57; rs10420252, OR = 1.68, 95% CI 1.11-2.53); rs6510502 Polymorphisms in the mitochondrial oxidative phosphorylation chain genes as prognostic markers for colorectal cancer. ## BACKGROUND
[ 2, 2288, 6084, 1922, 1920, 23, 11, 19522, 3031, 1927, 63, 17767, 16007, 12, 2796, 4337, 13, 16, 26570, 11368, 7283, 8364, 1930, 28810, 3382, 7196, 9171, 16, 1985, 2458, 1956, 3399, 3298, 12, 3668, 33, 20, 18, 4764, 16, 3002, 9, 3371, 20, 18, 3323, 17, 20, 18, 5140, 1930, 3668, 33, 20, 18, 4723, 16, 3002, 9, 3371, 20, 18, 3858, 17, 20, 18, 4922, 16, 1958, 7382, 8974, 13, 18, 2144, 5253, 1985, 6715, 1942, 1920, 2210, 1927, 2132, 1956, 2539, 4810, 1922, 1920, 4120, 12, 3668, 33, 20, 18, 3858, 16, 3002, 9, 3371, 20, 18, 2950, 17, 20, 18, 6175, 1930, 3668, 33, 20, 18, 4182, 16, 3002, 9, 3371, 20, 18, 2637, 17, 20, 18, 5893, 13, 18, 6884, 2333, 3391, 1988, 2321, 4432, 3284, 4033, 1966, 3484, 6750, 4432, 18, 4950, 16, 1920, 7382, 8974, 1985, 72, 22, 3586, 2253, 3205, 1942, 2392, 9313, 1922, 1920, 4120, 2254, 1922, 1920, 19773, 18, 2288, 6084, 1922, 6374, 22022, 1009, 12, 2796, 4370, 13, 1985, 2458, 1956, 3541, 6267, 5967, 1922, 43, 6379, 2322, 12, 4366, 5964, 14234, 11636, 16, 2014, 33, 21, 18, 4089, 16, 3002, 9, 3371, 21, 18, 2036, 17, 22, 18, 4786, 31, 28810, 6852, 11636, 8982, 4366, 5964, 14234, 11636, 16, 2014, 33, 21, 18, 4089, 16, 3002, 9, 3371, 21, 18, 2036, 17, 22, 18, 4786, 31, 28810, 6852, 11636, 8982, 16, 2014, 33, 21, 18, 5117, 16, 3002, 9, 3371, 21, 18, 2513, 17, 22, 18, 4522, 13, 31, 4366, 5964, 14234, 11636, 8321, 1922, 1920, 4596, 5163, 4050, 4659, 2628, 1966, 6750, 4432, 1958, 7820, 2539, 18, 7, 7, 3872, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 12, 12, 12, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 12, 12, 12, 11, 12, 12, 12, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 11, 12, 12, 12, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
12530077
[ "Amplified", "Muc1-specific", "gene", "expression", "in", "colon", "cancer", "cells", "utilizing", "a", "binary", "system", "in", "adenoviral", "vectors." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Amplified Muc1-specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectors.
[ 2, 7006, 21215, 17, 2487, 2359, 2294, 1922, 4120, 2539, 2094, 10232, 43, 9921, 2433, 1922, 22870, 7623, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
23132392
[ "##", "METHODS" ]
[ 0, 0 ]
## METHODS
[ 2, 7, 7, 2860, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
26416897
[ "We", "analyzed", "genomic", "DNA", "extracted", "from", "samples", "of", "patients", "receiving", "bevacizumab", "plus", "FOLFIRI", "as", "a", "first-line", "treatment", "using", "PCR-based", "direct", "sequencing.", "Twelve", "functional", "single-nucleotide", "polymorphisms", "in", "eight", "genes", "(CCL2,", "CCR2,", "HRG,", "PIGF,", "NFKB1,", "TBK1,", "CCL18,", "and", "IRF3)", "were", "tested", "for", "associations", "with", "clinical", "outcomes", "in", "a", "discovery", "cohort", "of", "228", "participants", "in", "TRIBE", "trial", "(NCT00719797),", "then", "validated", "in", "248", "KRAS", "exon2", "(KRAS)", "wild-type", "participants", "in", "FIRE3", "trial", "(NCT00433927).", "FIRE3-cetuximab", "cohort", "served", "as", "a", "negative", "control." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We analyzed genomic DNA extracted from samples of patients receiving bevacizumab plus FOLFIRI as a first-line treatment using PCR-based direct sequencing. Twelve functional single-nucleotide polymorphisms in eight genes (CCL2, CCR2, HRG, PIGF, NFKB1, TBK1, CCL18, and IRF3) were tested for associations with clinical outcomes in a discovery cohort of 228 participants in TRIBE trial (NCT00719797), then validated in 248 KRAS exon2 (KRAS) wild-type participants in FIRE3 trial (NCT00433927). FIRE3-cetuximab cohort served as a negative control.
[ 2, 2038, 3265, 4935, 2678, 5210, 2037, 2785, 1927, 2132, 5962, 15250, 5390, 17802, 30480, 1033, 1966, 43, 2561, 17, 2823, 2311, 2193, 3343, 17, 2454, 3083, 4754, 18, 12367, 3183, 2957, 17, 5489, 8321, 1922, 5066, 2628, 12, 18280, 16, 23915, 16, 3668, 1029, 16, 5445, 1038, 16, 4651, 11228, 1009, 16, 28847, 16, 10322, 3928, 16, 1930, 23827, 13, 1985, 3620, 1958, 5253, 1956, 2535, 3685, 1922, 43, 7139, 4382, 1927, 19650, 3003, 1922, 14521, 1021, 3046, 12, 29287, 9948, 8528, 8528, 13, 16, 2759, 6593, 1922, 21103, 11083, 7049, 1028, 12, 11083, 13, 3576, 17, 2601, 3003, 1922, 11105, 1010, 3046, 12, 29287, 7514, 6021, 4282, 13, 18, 11105, 1010, 17, 19418, 4382, 9599, 1966, 43, 3136, 2285, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
22899730
[ "The", "presence", "of", "a", "BRAF", "c.1799T>A", "(p.V600E)", "mutation", "mutation", " ", "and", "MSI", "status.", "We", "used", "Cox", "regression", "to", "estimate", "HRs", "and", "95%", "confidence", "intervals", "(CI)", "for", "the", "association", "between", "BRAF", "mutation", "status", "and", "disease-specific", "and", "overall", "survival.", "Stratified", "analyses", "were", "conducted", "by", "age,", "sex,", "tumor", "site,", "stage,", "and", "MSI", "status." ]
[ 0, 0, 0, 0, 0, 0, 0, 9, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The presence of a BRAF c.1799T>A (p.V600E) mutation mutation and MSI status. We used Cox regression to estimate HRs and 95% confidence intervals (CI) for the association between BRAF mutation status and disease-specific and overall survival. Stratified analyses were conducted by age, sex, tumor site, stage, and MSI status.
[ 2, 1920, 2990, 1927, 43, 11346, 45, 18, 16182, 1026, 1031, 34, 43, 12, 58, 18, 23727, 13, 3979, 3979, 1930, 17355, 3642, 18, 2038, 2251, 6374, 4165, 1942, 5383, 10079, 1930, 3002, 9, 5203, 6087, 12, 3371, 13, 1958, 1920, 3279, 2192, 11346, 3979, 3642, 1930, 2573, 17, 2487, 1930, 3399, 3298, 18, 9536, 3247, 1985, 3609, 2007, 2632, 16, 3486, 16, 2798, 3200, 16, 3587, 16, 1930, 17355, 3642, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
18554281
[]
[]
[ 2, 3 ]
[ 0, 0 ]
[ 1, 1 ]
[ -100, -100 ]
11521793
[]
[]
[ 2, 3 ]
[ 0, 0 ]
[ 1, 1 ]
[ -100, -100 ]
25374237
[ "##", "MATERIALS", "AND", "METHODS" ]
[ 0, 0, 0, 0 ]
## MATERIALS AND METHODS
[ 2, 7, 7, 4751, 1930, 2860, 3 ]
[ 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, -100 ]
22899730
[ "Among", "1,980", "cases", "tested,", "12%", "were", "BRAF", "c.1799T>A", "(p.V600E)", "mutation-positive", "(n", "=", "247).", "BRAF-mutated", "CRC", "was", "associated", "with", "poorer", "disease-specific", "survival", "adjusting", "for", "age,", "sex,", "time", "from", "diagnosis", "to", "enrollment,", "stage,", "and", "MSI", "status", "(HR,", "1.43;", "95%", "CI,", "1.05-1.95).", "This", "association", "was", "limited", "to", "cases", "diagnosed", "at", "ages", "<50", "(HR,", "3.06;", "95%", "CI,", "1.70-5.52)", "and", "was", "not", "evident", "in", "cases", "with", "MSI-high", "tumors", "(HR,", "0.94;", "95%", "CI,", "0.44-2.03).", "Associations", "with", "overall", "survival", "were", "similar." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Among 1,980 cases tested, 12% were BRAF c.1799T>A (p.V600E) mutation-positive (n = 247). BRAF-mutated CRC was associated with poorer disease-specific survival adjusting for age, sex, time from diagnosis to enrollment, stage, and MSI status (HR, 1.43; 95% CI, 1.05-1.95). This association was limited to cases diagnosed at ages <50 (HR, 3.06; 95% CI, 1.70-5.52) and was not evident in cases with MSI-high tumors (HR, 0.94; 95% CI, 0.44-2.03). Associations with overall survival were similar.
[ 2, 2706, 21, 16, 28399, 2919, 3620, 16, 2369, 9, 1985, 11346, 45, 18, 16182, 1026, 1031, 34, 43, 12, 58, 18, 23727, 13, 3979, 17, 2843, 12, 56, 33, 20892, 13, 18, 11346, 17, 8336, 8223, 1982, 2458, 1956, 11667, 2573, 17, 2487, 3298, 9772, 1958, 2632, 16, 3486, 16, 2367, 2037, 3574, 1942, 11811, 16, 3587, 16, 1930, 17355, 3642, 12, 3668, 16, 21, 18, 3941, 31, 3002, 9, 3371, 16, 21, 18, 2914, 17, 21, 18, 3002, 13, 18, 2052, 3279, 1982, 3892, 1942, 2919, 5377, 2019, 7684, 32, 2761, 12, 3668, 16, 23, 18, 6604, 31, 3002, 9, 3371, 16, 21, 18, 3895, 17, 25, 18, 4764, 13, 1930, 1982, 2084, 7501, 1922, 2919, 1956, 17355, 17, 2149, 3861, 12, 3668, 16, 20, 18, 5650, 31, 3002, 9, 3371, 16, 20, 18, 4044, 17, 22, 18, 5167, 13, 18, 5253, 1956, 3399, 3298, 1985, 2551, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
9476377
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
17186357
[ "The", "GNAS1", "locus", "encodes", "the", "G(alpha)s", "protein", "G", "protein", " ", "is", "associated", "with", "survival", "of", "patients", "with", "invasive", "breast", "carcinoma." ]
[ 0, 0, 0, 0, 0, 1, 2, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The GNAS1 locus encodes the G(alpha)s protein G protein is associated with survival of patients with invasive breast carcinoma.
[ 2, 1920, 9005, 26456, 6730, 9937, 1920, 49, 12, 4595, 13, 61, 2213, 49, 2213, 1977, 2458, 1956, 3298, 1927, 2132, 1956, 6044, 3739, 5373, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
16924054
[ "##", "CONCLUSION" ]
[ 0, 0 ]
## CONCLUSION
[ 2, 7, 7, 4180, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
9609758
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
11521793
[ "Cancer", "genetics", "in", "oncology", "practice." ]
[ 0, 0, 0, 0, 0 ]
Cancer genetics in oncology practice.
[ 2, 2539, 10072, 1922, 11605, 4695, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, -100 ]
22545919
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
22899730
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
22810479
[ "##", "OBJECTIVE" ]
[ 0, 0 ]
## OBJECTIVE
[ 2, 7, 7, 4470, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
16924054
[ "##", "CONCLUSION" ]
[ 0, 0 ]
## CONCLUSION
[ 2, 7, 7, 4180, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
9731891
[ "In", "the", "125", "cases", "studied,", "there", "were", "53", "tumors", "with", "mutations", "of", "the", "p53", "gene.", "p53", "mutations", "correlated", "with", "lymph", "node", "metastases", "from", "right", "colon", "carcinoma", "cases", "(61%),", "and", "all", "cases", "with", "p53", "mutations", "and", "microsatellite", "instability", "were", "AJCC/UICC", "Stage", "III", "(Dukes", "Stage", "C).", "In", "the", "right", "colon", "carcinoma", "cases", "the", "rate", "of", "microsatellite", "instability", "was", "related", "to", "the", "tumor", "size", "(19%", "in", "tumors", "measuring", "<", "4", "cm,", "and", "34%", "in", "tumors", "measuring", ">", "4", "cm).", "No", "correlation", "between", "microsatellite", "instability", "and", "p53", "mutations", "was", "detected.", "In", "the", "left", "colon", "carcinoma", "cases,", "p53", "mutations", "were", "detected", "in", "41%", "of", "tumors", "and", "microsatellite", "instability", "in", "14%;", "neither", "finding", "was", "related", "to", "the", "tumor", "size.", "Mutations", "of", "the", "hMLH1", "and", "hMSH2", "mismatch", "repair", "genes", "were", "detected", "in", "7", "of", "24", "cases", "with", "marked", "microsatellite", "instability." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
In the 125 cases studied, there were 53 tumors with mutations of the p53 gene. p53 mutations correlated with lymph node metastases from right colon carcinoma cases (61%), and all cases with p53 mutations and microsatellite instability were AJCC/UICC Stage III (Dukes Stage C). In the right colon carcinoma cases the rate of microsatellite instability was related to the tumor size (19% in tumors measuring < 4 cm, and 34% in tumors measuring > 4 cm). No correlation between microsatellite instability and p53 mutations was detected. In the left colon carcinoma cases, p53 mutations were detected in 41% of tumors and microsatellite instability in 14%; neither finding was related to the tumor size. Mutations of the hMLH1 and hMSH2 mismatch repair genes were detected in 7 of 24 cases with marked microsatellite instability.
[ 2, 1922, 1920, 7151, 2919, 3942, 16, 2276, 1985, 4522, 3861, 1956, 3527, 1927, 1920, 5105, 2359, 18, 5105, 3527, 4374, 1956, 3541, 6267, 8174, 2037, 3659, 4120, 5373, 2919, 12, 5473, 9, 13, 16, 1930, 2136, 2919, 1956, 5105, 3527, 1930, 16069, 9557, 1985, 13937, 2437, 19, 20487, 2437, 3587, 4337, 12, 26101, 1036, 3587, 45, 13, 18, 1922, 1920, 3659, 4120, 5373, 2919, 1920, 2769, 1927, 16069, 9557, 1982, 2712, 1942, 1920, 2798, 3081, 12, 2282, 9, 1922, 3861, 6711, 32, 24, 3195, 16, 1930, 3540, 9, 1922, 3861, 6711, 34, 24, 3195, 13, 18, 2239, 3670, 2192, 16069, 9557, 1930, 5105, 3527, 1982, 3330, 18, 1922, 1920, 3506, 4120, 5373, 2919, 16, 5105, 3527, 1985, 3330, 1922, 4353, 9, 1927, 3861, 1930, 16069, 9557, 1922, 2607, 9, 31, 7132, 2849, 1982, 2712, 1942, 1920, 2798, 3081, 18, 3527, 1927, 1920, 5833, 1024, 8600, 1930, 21904, 6951, 10265, 5059, 2628, 1985, 3330, 1922, 27, 1927, 2686, 2919, 1956, 4961, 16069, 9557, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
19706845
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
24568449
[ "##", "METHODOLOGY/PRINCIPAL", "FINDINGS" ]
[ 0, 0, 0 ]
## METHODOLOGY/PRINCIPAL FINDINGS
[ 2, 7, 7, 8087, 19, 7944, 3056, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, -100 ]
8431846
[ "The", "authors", "report", "the", "case", "of", "a", "48-year-old", "woman", "with", "rectal", "cancer", "accompanied", "by", "multiple", "polyps", "in", "the", "esophagus,", "stomach,", "and", "colorectum.", "Histologically,", "the", "polypoid", "lesions", "in", "the", "esophagus,", "stomach,", "and", "colorectum", "showed", "a", "thickened", "mucosa,", "hyperplastic", "polyps,", "and", "mixed", "hyperplastic", "adenomatous", "polyps,", "respectively.", "Karyotype", "analysis", "showed", "46,", "xx,", "inv(3)(p12.2q25.3)", "in", "all", "20", "inspected", "peripheral", "lymphocytes.", "By", "Southern", "blot", "with", "a", "c-raf", "probe,", "one", "allele", "of", "the", "c-raf-1", "gene,", "which", "has", "been", "mapped", "on", "chromosome", "3p25", "c-raf-1", " ", "gene,", "which", "has", "been", "mapped", "on", "chromosome", "3p25,", "was", "deleted", " ", "from", "the", "rearranged", "chromosome", "3", " ", "in", "the", "peripheral", "lymphocytes,", "intact", "colonic", "mucosa,", "and", "cancer", "tissue." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The authors report the case of a 48-year-old woman with rectal cancer accompanied by multiple polyps in the esophagus, stomach, and colorectum. Histologically, the polypoid lesions in the esophagus, stomach, and colorectum showed a thickened mucosa, hyperplastic polyps, and mixed hyperplastic adenomatous polyps, respectively. Karyotype analysis showed 46, xx, inv(3)(p12.2q25.3) in all 20 inspected peripheral lymphocytes. By Southern blot with a c-raf probe, one allele of the c-raf-1 gene, which has been mapped on chromosome 3p25 c-raf-1 gene, which has been mapped on chromosome 3p25, was deleted from the rearranged chromosome 3 in the peripheral lymphocytes, intact colonic mucosa, and cancer tissue.
[ 2, 1920, 3875, 3809, 1920, 3087, 1927, 43, 3427, 17, 2476, 17, 4156, 10440, 1956, 11635, 2539, 7936, 2007, 3137, 17410, 1922, 1920, 16749, 16, 11399, 16, 1930, 4677, 2089, 1989, 18, 15055, 16, 1920, 6240, 2642, 4518, 1922, 1920, 16749, 16, 11399, 16, 1930, 4677, 2089, 1989, 2594, 43, 25981, 9680, 16, 28733, 17410, 16, 1930, 4985, 28733, 30390, 17410, 16, 2763, 18, 21954, 2333, 2594, 4182, 16, 22995, 16, 2269, 12, 23, 13, 12, 28443, 18, 22, 23470, 1015, 18, 23, 13, 1922, 2136, 2036, 23396, 5009, 7257, 18, 2007, 9257, 4918, 1956, 43, 45, 17, 12783, 5598, 16, 2340, 5465, 1927, 1920, 45, 17, 12783, 17, 21, 2359, 16, 2154, 2258, 2252, 9225, 1990, 5597, 11469, 4198, 45, 17, 12783, 17, 21, 2359, 16, 2154, 2258, 2252, 9225, 1990, 5597, 11469, 4198, 16, 1982, 11782, 2037, 1920, 26669, 5597, 23, 1922, 1920, 5009, 7257, 16, 6718, 12401, 9680, 16, 1930, 2539, 2960, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 7, 8, 8, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
23096495
[ "The", "activity", "of", "phosphatases", "could", "be", "influenced", "by", "genetic,", "as", "well", "as", "epigenetic", "alterations.", "In", "our", "study,", "we", "have", "investigated", "the", "methylation", "status", "of", "four", "PTPRs:", "PTPRM,", "PTPRT,", "PTPRR", "and", "PTPRZ1,", "which", "were", "pre-selected", "using", "microarray", "techniques", "as", "being", "alternatively", "methylated", "in", "sporadic", "colorectal", "cancer", "(CRC).", "The", "analyses", "were", "carried", "out", "on", "131", "surgical", "specimens", "obtained", "from", "sporadic", "CRC", "patients.", "The", "methylation", "status", "of", "the", "four", "genes", "was", "examined", "using", "methyl", "specific", "PCR", "(MSP).", "The", "analysis", "of", "promoter", "methylation", "using", "an", "Illumina", "27K", "microarray", "revealed", "four", "protein", "tyrosine", "phosphatases", "PTPRM,", "PTPRT,", "PTPRR", "and", "PTPRZ1", "as", "being", "hypermethylated", "with", "β-value", "≥0.2", "and", "P≤0.05.", "Subsequent", "analysis", "using", "MSP", "confirmed", "these", "observations-the", "frequency", "of", "promoter", "methylation", "was", "significantly", "higher", "in", "tumor", "cells", "compared", "with", "matched", "normal", "tissue", "for", "each", "of", "the", "analyzed", "genes.", "There", "was", "no", "association", "observed", "between", "the", "methylation", "status", "of", "PTPRs", "and", "either", "CIMP,", "K-ras", "(codon", "12)", "and", "BRAF", "(exon", "15,", "V600E)", "mutations", "or", "tumor", "localization", "(proximal/distal).", "The", "results", "of", "our", "study", "show", "a", "statistically", "significant", "difference", "between", "promoter", "methylation", "in", "cancerous", "and", "healthy", "tissue.", "This", "result", "supports", "the", "hypothesis", "that", "the", "PTPR", "family", "has", "an", "important", "role", "in", "the", "etiology", "of", "CRC." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The activity of phosphatases could be influenced by genetic, as well as epigenetic alterations. In our study, we have investigated the methylation status of four PTPRs: PTPRM, PTPRT, PTPRR and PTPRZ1, which were pre-selected using microarray techniques as being alternatively methylated in sporadic colorectal cancer (CRC). The analyses were carried out on 131 surgical specimens obtained from sporadic CRC patients. The methylation status of the four genes was examined using methyl specific PCR (MSP). The analysis of promoter methylation using an Illumina 27K microarray revealed four protein tyrosine phosphatases PTPRM, PTPRT, PTPRR and PTPRZ1 as being hypermethylated with β-value ≥0.2 and P≤0.05. Subsequent analysis using MSP confirmed these observations-the frequency of promoter methylation was significantly higher in tumor cells compared with matched normal tissue for each of the analyzed genes. There was no association observed between the methylation status of PTPRs and either CIMP, K-ras (codon 12) and BRAF (exon 15, V600E) mutations or tumor localization (proximal/distal). The results of our study show a statistically significant difference between promoter methylation in cancerous and healthy tissue. This result supports the hypothesis that the PTPR family has an important role in the etiology of CRC.
[ 2, 1920, 2455, 1927, 19131, 2578, 1998, 6950, 2007, 3299, 16, 1966, 2486, 1966, 8542, 5996, 18, 1922, 2342, 2161, 16, 2038, 2162, 3845, 1920, 5547, 3642, 1927, 3006, 14990, 5675, 30, 14990, 23745, 16, 14990, 7446, 16, 14990, 18858, 1930, 14990, 1005, 23982, 16, 2154, 1985, 2097, 17, 3790, 2193, 7850, 4941, 1966, 3301, 9242, 11882, 1922, 13088, 7820, 2539, 12, 8223, 13, 18, 1920, 3247, 1985, 4371, 2397, 1990, 11389, 4548, 5864, 2926, 2037, 13088, 8223, 2132, 18, 1920, 5547, 3642, 1927, 1920, 3006, 2628, 1982, 3572, 2193, 4963, 2487, 3343, 12, 22064, 13, 18, 1920, 2333, 1927, 4465, 5547, 2193, 1925, 10379, 3225, 1040, 7850, 3404, 3006, 2213, 6941, 19131, 14990, 23745, 16, 14990, 7446, 16, 14990, 18858, 1930, 14990, 1005, 23982, 1966, 3301, 13317, 15890, 1956, 161, 17, 3113, 25889, 18, 22, 1930, 21247, 18, 2914, 18, 4521, 2333, 2193, 22064, 3982, 2144, 5184, 17, 1920, 3528, 1927, 4465, 5547, 1982, 2567, 2580, 1922, 2798, 2094, 2452, 1956, 5992, 2791, 2960, 1958, 2362, 1927, 1920, 3265, 2628, 18, 2276, 1982, 2239, 3279, 2528, 2192, 1920, 5547, 3642, 1927, 14990, 5675, 1930, 3108, 20090, 1034, 16, 53, 17, 6520, 12, 8905, 2369, 13, 1930, 11346, 12, 7049, 2461, 16, 23727, 13, 3527, 2014, 2798, 5363, 12, 6863, 19, 6583, 13, 18, 1920, 2274, 1927, 2342, 2161, 2146, 43, 4388, 2228, 3175, 2192, 4465, 5547, 1922, 18880, 1930, 4097, 2960, 18, 2052, 3211, 7825, 1920, 4676, 1988, 1920, 14990, 1005, 3416, 2258, 1925, 2715, 2770, 1922, 1920, 10383, 1927, 8223, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
21479914
[]
[]
[ 2, 3 ]
[ 0, 0 ]
[ 1, 1 ]
[ -100, -100 ]
22810479
[ "##", "MAIN", "OUTCOME", "MEASURES" ]
[ 0, 0, 0, 0 ]
## MAIN OUTCOME MEASURES
[ 2, 7, 7, 2730, 3924, 3975, 3 ]
[ 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, -100 ]
26416897
[ "Tumor-associated", "macrophages", "(TAMs)", "with", "the", "M2-like", "phenotype", "are", "regulated", "by", "mainly", "NF-kB", "pathway", "including", "TBK1,", "which", "can", "influence", "tumor", "progression", "by", "secretion", "of", "proangiogenic", "factors", "such", "as", "vascular", "endothelial", "growth", "factor", ".", "The", "CCL2/CCR2", "axis,", "histidine-rich", "glycoprotein", "(HRG),", "and", "placenta", "growth", "factor", "(PIGF)", "play", "a", "critical", "role", "in", "the", "polarization", "of", "M1/M2", "phenotypes", "and", "the", "recruitment", "of", "TAMs", "to", "tumor", "microenvironment.", "We", "therefore", "hypothesized", "that", "variations", "in", "genes", "involved", "in", "regulating", "TAMs", "may", "predict", "clinical", "outcomes", "of", "bevacizumab", "treatment", "in", "patients", "with", "metastatic", "colorectal", "cancer", "(mCRC)." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Tumor-associated macrophages (TAMs) with the M2-like phenotype are regulated by mainly NF-kB pathway including TBK1, which can influence tumor progression by secretion of proangiogenic factors such as vascular endothelial growth factor . The CCL2/CCR2 axis, histidine-rich glycoprotein (HRG), and placenta growth factor (PIGF) play a critical role in the polarization of M1/M2 phenotypes and the recruitment of TAMs to tumor microenvironment. We therefore hypothesized that variations in genes involved in regulating TAMs may predict clinical outcomes of bevacizumab treatment in patients with metastatic colorectal cancer (mCRC).
[ 2, 2798, 17, 2458, 5205, 12, 23775, 13, 1956, 1920, 6056, 17, 3189, 4629, 2032, 4335, 2007, 4994, 4651, 17, 6633, 3374, 2710, 28847, 16, 2154, 2112, 4039, 2798, 4380, 2007, 5512, 1927, 1965, 21444, 2790, 2427, 1966, 4541, 5003, 2905, 2991, 18, 1920, 18280, 19, 23915, 5432, 16, 13873, 17, 5536, 11424, 12, 3668, 1029, 13, 16, 1930, 13752, 2905, 2991, 12, 5445, 1038, 13, 3918, 43, 4140, 2770, 1922, 1920, 10839, 1927, 8510, 19, 6056, 6568, 1930, 1920, 6067, 1927, 23775, 1942, 2798, 10236, 18, 2038, 2955, 7149, 1988, 6740, 1922, 2628, 3286, 1922, 6773, 23775, 2278, 5660, 2535, 3685, 1927, 15250, 2311, 1922, 2132, 1956, 6476, 7820, 2539, 12, 17379, 1030, 13, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
14734469
[ "BRAF", "hMLH1", ",", "whereas", "only", "4", "of", "91", "(4%)", "of", "the", "cell", "lines", "and", "cancers", "with", "unmethylated", "hMLH1", "carried", "the", "mutations", "(P", "<", "0.00001).", "Sixteen", "of", "17", "mutations", "were", "at", "residue", "599", "(V599E).", "A", "BRAF", "mutation", "was", "also", "identified", "at", "residue", "463", "(G463V)", "in", "one", "cell", "line.", "In", "addition,", "BRAF", "mutations", "were", "not", "found", "in", "any", "cancers", "or", "cell", "lines", "with", "K-ras", "mutations.", "In", "20", "MSI+", "cancers", "from", "HNPCC", "patients,", "however,", "BRAF", "mutations", "were", "not", "detectable,", "including", "a", "subset", "of", "9", "tumors", "with", "negative", "hMLH1", "immunostaining", "and", "methylated", "hMLH1." ]
[ 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BRAF hMLH1 , whereas only 4 of 91 (4%) of the cell lines and cancers with unmethylated hMLH1 carried the mutations (P < 0.00001). Sixteen of 17 mutations were at residue 599 (V599E). A BRAF mutation was also identified at residue 463 (G463V) in one cell line. In addition, BRAF mutations were not found in any cancers or cell lines with K-ras mutations. In 20 MSI+ cancers from HNPCC patients, however, BRAF mutations were not detectable, including a subset of 9 tumors with negative hMLH1 immunostaining and methylated hMLH1.
[ 2, 11346, 5833, 1024, 8600, 16, 3417, 2444, 24, 1927, 6550, 12, 24, 9, 13, 1927, 1920, 2024, 3557, 1930, 5717, 1956, 24416, 5833, 1024, 8600, 4371, 1920, 3527, 12, 58, 32, 20, 18, 27133, 13, 18, 18466, 1927, 2752, 3527, 1985, 2019, 6181, 4777, 1026, 12, 16382, 6576, 1021, 13, 18, 43, 11346, 3979, 1982, 2222, 2899, 2019, 6181, 4182, 1010, 12, 14036, 7576, 1020, 13, 1922, 2340, 2024, 2823, 18, 1922, 2459, 16, 11346, 3527, 1985, 2084, 2435, 1922, 2967, 5717, 2014, 2024, 3557, 1956, 53, 17, 6520, 3527, 18, 1922, 2036, 17355, 15, 5717, 2037, 9888, 7693, 1030, 2132, 16, 2406, 16, 11346, 3527, 1985, 2084, 7398, 16, 2710, 43, 6728, 1927, 29, 3861, 1956, 3136, 5833, 1024, 8600, 10930, 1930, 11882, 5833, 1024, 8600, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 1, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
3399825
[ "Increased", "in", "vitro", "tetraploidy", "and", "mandibular", "osteomas", "in", "patients", "with", "and", "without", "colorectal", "diseases." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Increased in vitro tetraploidy and mandibular osteomas in patients with and without colorectal diseases.
[ 2, 2502, 1922, 3596, 29389, 1012, 1930, 14951, 4416, 4956, 1922, 2132, 1956, 1930, 2979, 7820, 3902, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
26302849
[ "We", "genotyped", "seven", "single", "nucleotide", "polymorphisms", "(SNPs)", "from", "seven", "genes.", "We", "selected", "588", "patients", "with", "gastric", "cancer", "and", "449", "with", "colorectal", "cancer,", "along", "with", "703", "healthy", "controls.", "All", "these", "SNPs", "were", "evaluated", "using", "the", "χ²", "test", "and", "genetic", "model", "analysis." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We genotyped seven single nucleotide polymorphisms (SNPs) from seven genes. We selected 588 patients with gastric cancer and 449 with colorectal cancer, along with 703 healthy controls. All these SNPs were evaluated using the χ² test and genetic model analysis.
[ 2, 2038, 14401, 5260, 2957, 5489, 8321, 12, 6084, 13, 2037, 5260, 2628, 18, 2038, 3790, 4804, 1025, 2132, 1956, 6319, 2539, 1930, 29010, 1956, 7820, 2539, 16, 4231, 1956, 3895, 1010, 4097, 3562, 18, 2136, 2144, 6084, 1985, 3747, 2193, 1920, 182, 1189, 2648, 1930, 3299, 2322, 2333, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
19276868
[ "The", "deleted", "in", "pancreatic", "cancer", "locus", "4", "(DPC4)/SMAD4", "tumor", "suppressor", "gene", "is", "frequently", "inactivated", "in", "pancreatic", "(approximately", "55%)", "and", "colorectal", "cancers", "(approximately", "30%).", "Like", "other", "tumor", "suppressor", "genes,", "the", "loss-of-function", "mutations", "found", "in", "the", "DPC4", "gene", "are", "specific", "to", "cancer", "cells.", "This", "provides", "an", "attractive", "and", "unique", "opportunity", "for", "therapeutic", "intervention.", "The", "aim", "of", "this", "study", "was", "to", "identify", "and", "characterize", "small", "molecules", "that", "selectively", "kill", "DPC4-deficient", "cancer", "cells." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The deleted in pancreatic cancer locus 4 (DPC4)/SMAD4 tumor suppressor gene is frequently inactivated in pancreatic (approximately 55%) and colorectal cancers (approximately 30%). Like other tumor suppressor genes, the loss-of-function mutations found in the DPC4 gene are specific to cancer cells. This provides an attractive and unique opportunity for therapeutic intervention. The aim of this study was to identify and characterize small molecules that selectively kill DPC4-deficient cancer cells.
[ 2, 1920, 11782, 1922, 6356, 2539, 6730, 24, 12, 25488, 1006, 13, 19, 22020, 2798, 9241, 2359, 1977, 5467, 11588, 1922, 6356, 12, 3993, 4288, 9, 13, 1930, 7820, 5717, 12, 3993, 2627, 9, 13, 18, 3189, 2303, 2798, 9241, 2628, 16, 1920, 3257, 17, 1927, 17, 2347, 3527, 2435, 1922, 1920, 25488, 1006, 2359, 2032, 2487, 1942, 2539, 2094, 18, 2052, 4558, 1925, 10974, 1930, 5008, 9202, 1958, 4272, 3280, 18, 1920, 3774, 1927, 2052, 2161, 1982, 1942, 3512, 1930, 8063, 2858, 4206, 1988, 9331, 11321, 25488, 1006, 17, 5778, 2539, 2094, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
26925673
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
9609758
[ "Sporadic", "colorectal", "cancers", "do", "not", "show", "an", "absence", "or", "a", "presence", "of", "mutated", "TGF-beta", "receptors", "mutation", " ", "was", "observed", "in", "the", "microsatellite-like", "regions", "of", "receptor", "II", "in", "any", "of", "the", "samples." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Sporadic colorectal cancers do not show an absence or a presence of mutated TGF-beta receptors mutation was observed in the microsatellite-like regions of receptor II in any of the samples.
[ 2, 13088, 7820, 5717, 2608, 2084, 2146, 1925, 3905, 2014, 43, 2990, 1927, 8336, 5525, 17, 4666, 4086, 3979, 1982, 2528, 1922, 1920, 16069, 17, 3189, 3451, 1927, 3148, 2890, 1922, 2967, 1927, 1920, 2785, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
9476377
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
22376259
[ "Single", "nucleotide", "polymorphisms", "(", "SNPs", "Single", "nucleotide", "polymorphisms", " ", "(SNPs)", "in", "the", "promoter", "and", "untranslated", "region", "of", "cyclooxygenase", "(COX)-2,", "an", "inducible", "enzyme", "responsible", "for", "the", "synthesis", "of", "prostaglandins,", "have", "been", "reported", "to", "modulate", "the", "risk", "for", "many", "human", "cancers.", "We", "performed", "comprehensive", "linkage", "disequilibrium", "(LD)", "and", "haplotype", "analyses", "of", "13", "single", "nucleotide", "polymorphisms", "of", "the", "COX-2", "gene", "and", "examined", "its", "susceptibility", "to", "adenoma", "development", "in", "72", "African", "American", "cases", "and", "142", "controls.", "Results", "revealed", "significant", "variation", "in", "LD", "patterns", "with", "consequence", "for", "adenoma", "development.", "Two", "distinct", "haplotype", "blocks", "were", "identified;", "one", "block", "covered", "the", "coding", "regions", "of", "exon", "1,", "introns", "and", "a", "section", "of", "the", "3'-unstranslated", "region", "(3'-UTR),", "whereas", "the", "second", "block", "resided", "solely", "in", "the", "3'-UTR", "region.", "A", "haplotype", "in", "block", "1", "increased", "the", "risk", "of", "adenoma", "development", "by", "threefold", "(odds", "ratio", "[OR]=", "2.9,", "confidence", "interval", "[CI]=", "1.8-3.7,", "P=", "0.002).", "Regression", "analysis", "showed,", "increase", "in", "copies", "of", "minor", "alleles", "of", "6,064(T>C)", "polymorphism", "associated", "with", "increased", "odds", "of", "adenoma", "development", "by", "80%", "(OR", "=", "1.80,", "CI", "=", "1.09-3.21,", "P=", "0.034),", "10,848(G>A)", "by", "84%", "(OR", "=", "1.84,", "CI", "=", "1.05-3.23,", "P=", "0.034)", "and", "10,935(", "A>G", "haplotype", "blocks", " ", "were", "identified;", "one", "block", "covered", "the", "coding", "regions", "of", "exon", "1,", "introns", "and", "a", "section", "of", "the", "3'-unstranslated", "region", "(3'-UTR),", "whereas", "the", "second", "block", "resided", "solely", "in", "the", "3'-UTR", "region.", "A", "haplotype", "in", "block", "1", "increased", "the", "risk", "of", "adenoma", "development", "by", "threefold", "(odds", "ratio", "[OR]=", "2.9,", "confidence", "interval", "[CI]=", "1.8-3.7,", "P=", "0.002).", "Regression", "analysis", "showed,", "increase", "in", "copies", "of", "minor", "alleles", "of", "6,064(T>C)", "polymorphism", "associated", "with", "increased", "odds", "of", "adenoma", "development", "by", "80%", "(OR", "=", "1.80,", "CI", "=", "1.09-3.21,", "P=", "0.034),", "10,848(", "G>A", ")", "by", "84%", "(OR", "=", "1.84,", "CI", "=", "1.05-3.23,", "P=", "0.034)", "and", "10,935(A>G)", "by", "32%", "(OR", "=", "1.32,", "CI", "=", "1.12-3.69,", "P=", "0.036).", "These", "results", "support", "the", "hypothesis", "that", "COX-2", "gene", "might", "play", "a", "role", "in", "the", "etiology", "of", "colon", "cancer", "and", "warrant", "further", "investigation", "in", "other", "cancers.", "Besides,", "these", "variations", "should", "be", "taken", "into", "account", "for", "disease-based", "association", "studies", "in", "which", "the", "COX-2", "polymorphism", "is", "considered", "as", "a", "candidate", "gene.", "Clin", "Trans", "Sci", "2012;", "Volume", "5:", "60-64." ]
[ 0, 0, 0, 0, 3, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Single nucleotide polymorphisms ( SNPs Single nucleotide polymorphisms (SNPs) in the promoter and untranslated region of cyclooxygenase (COX)-2, an inducible enzyme responsible for the synthesis of prostaglandins, have been reported to modulate the risk for many human cancers. We performed comprehensive linkage disequilibrium (LD) and haplotype analyses of 13 single nucleotide polymorphisms of the COX-2 gene and examined its susceptibility to adenoma development in 72 African American cases and 142 controls. Results revealed significant variation in LD patterns with consequence for adenoma development. Two distinct haplotype blocks were identified; one block covered the coding regions of exon 1, introns and a section of the 3'-unstranslated region (3'-UTR), whereas the second block resided solely in the 3'-UTR region. A haplotype in block 1 increased the risk of adenoma development by threefold (odds ratio [OR]= 2.9, confidence interval [CI]= 1.8-3.7, P= 0.002). Regression analysis showed, increase in copies of minor alleles of 6,064(T>C) polymorphism associated with increased odds of adenoma development by 80% (OR = 1.80, CI = 1.09-3.21, P= 0.034), 10,848(G>A) by 84% (OR = 1.84, CI = 1.05-3.23, P= 0.034) and 10,935( A>G haplotype blocks were identified; one block covered the coding regions of exon 1, introns and a section of the 3'-unstranslated region (3'-UTR), whereas the second block resided solely in the 3'-UTR region. A haplotype in block 1 increased the risk of adenoma development by threefold (odds ratio [OR]= 2.9, confidence interval [CI]= 1.8-3.7, P= 0.002). Regression analysis showed, increase in copies of minor alleles of 6,064(T>C) polymorphism associated with increased odds of adenoma development by 80% (OR = 1.80, CI = 1.09-3.21, P= 0.034), 10,848( G>A ) by 84% (OR = 1.84, CI = 1.05-3.23, P= 0.034) and 10,935(A>G) by 32% (OR = 1.32, CI = 1.12-3.69, P= 0.036). These results support the hypothesis that COX-2 gene might play a role in the etiology of colon cancer and warrant further investigation in other cancers. Besides, these variations should be taken into account for disease-based association studies in which the COX-2 polymorphism is considered as a candidate gene. Clin Trans Sci 2012; Volume 5: 60-64.
[ 2, 2957, 5489, 8321, 12, 6084, 2957, 5489, 8321, 12, 6084, 13, 1922, 1920, 4465, 1930, 19522, 3031, 1927, 21271, 12, 6374, 13, 17, 22, 16, 1925, 9376, 4113, 5061, 1958, 1920, 4271, 1927, 25674, 16, 2162, 2252, 2568, 1942, 8480, 1920, 2565, 1958, 3086, 2616, 5717, 18, 2038, 2593, 6911, 8611, 19264, 12, 5091, 13, 1930, 10949, 3247, 1927, 2590, 2957, 5489, 8321, 1927, 1920, 6374, 17, 22, 2359, 1930, 3572, 2496, 6461, 1942, 16530, 2740, 1922, 4395, 7050, 5339, 2919, 1930, 13680, 3562, 18, 2274, 3404, 2228, 4516, 1922, 5091, 4147, 1956, 7749, 1958, 16530, 2740, 18, 2288, 4493, 10949, 7644, 1985, 2899, 31, 2340, 3367, 8710, 1920, 5804, 3451, 1927, 7049, 21, 16, 15778, 1930, 43, 3314, 1927, 1920, 23, 11, 17, 10769, 17182, 1036, 15793, 3031, 12, 23, 11, 17, 8812, 13, 16, 3417, 1920, 2812, 3367, 17305, 1007, 10870, 1922, 1920, 23, 11, 17, 8812, 3031, 18, 43, 10949, 1922, 3367, 21, 2502, 1920, 2565, 1927, 16530, 2740, 2007, 23109, 12, 6408, 3400, 37, 2014, 39, 33, 22, 18, 29, 16, 5203, 4979, 37, 3371, 39, 33, 21, 18, 28, 17, 23, 18, 27, 16, 58, 33, 20, 18, 9299, 13, 18, 4165, 2333, 2594, 16, 2760, 1922, 9425, 1927, 5857, 7096, 1927, 26, 16, 6604, 1006, 12, 62, 34, 45, 13, 8218, 2458, 1956, 2502, 6408, 1927, 16530, 2740, 2007, 3729, 9, 12, 2014, 33, 21, 18, 3729, 16, 3371, 33, 21, 18, 7102, 17, 23, 18, 2900, 16, 58, 33, 20, 18, 22207, 13, 16, 2119, 16, 5686, 1025, 12, 49, 34, 43, 13, 2007, 5686, 9, 12, 2014, 33, 21, 18, 5686, 16, 3371, 33, 21, 18, 2914, 17, 23, 18, 3020, 16, 58, 33, 20, 18, 22207, 13, 1930, 2119, 16, 6156, 1015, 12, 43, 34, 49, 10949, 7644, 1985, 2899, 31, 2340, 3367, 8710, 1920, 5804, 3451, 1927, 7049, 21, 16, 15778, 1930, 43, 3314, 1927, 1920, 23, 11, 17, 10769, 17182, 1036, 15793, 3031, 12, 23, 11, 17, 8812, 13, 16, 3417, 1920, 2812, 3367, 17305, 1007, 10870, 1922, 1920, 23, 11, 17, 8812, 3031, 18, 43, 10949, 1922, 3367, 21, 2502, 1920, 2565, 1927, 16530, 2740, 2007, 23109, 12, 6408, 3400, 37, 2014, 39, 33, 22, 18, 29, 16, 5203, 4979, 37, 3371, 39, 33, 21, 18, 28, 17, 23, 18, 27, 16, 58, 33, 20, 18, 9299, 13, 18, 4165, 2333, 2594, 16, 2760, 1922, 9425, 1927, 5857, 7096, 1927, 26, 16, 6604, 1006, 12, 62, 34, 45, 13, 8218, 2458, 1956, 2502, 6408, 1927, 16530, 2740, 2007, 3729, 9, 12, 2014, 33, 21, 18, 3729, 16, 3371, 33, 21, 18, 7102, 17, 23, 18, 2900, 16, 58, 33, 20, 18, 22207, 13, 16, 2119, 16, 5686, 1025, 12, 49, 34, 43, 13, 2007, 5686, 9, 12, 2014, 33, 21, 18, 5686, 16, 3371, 33, 21, 18, 2914, 17, 23, 18, 3020, 16, 58, 33, 20, 18, 22207, 13, 1930, 2119, 16, 6156, 1015, 12, 43, 34, 49, 13, 2007, 3323, 9, 12, 2014, 33, 21, 18, 3323, 16, 3371, 33, 21, 18, 2369, 17, 23, 18, 5349, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 3, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 7, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
26416897
[ "TBK1", "rs7486100", "was", "significantly", "associated", "with", "overall", "survival", "in", "95", "KRAS", "wild-type", "patients", "of", "TRIBE", "cohort", "in", "univariate", "analysis", "and", "had", "a", "strong", "trend", "in", "multivariable", "analysis;", "furthermore,", "the", "association", "of", "the", "T", "allele", "was", "observed", "for", "progression-free", "survival", "(PFS)", "in", "both", "univariate", "and", "multivariable", "analyses", "in", "FIRE3-bevacizumab", "but", "not", "cetuximab", "cohort.", "CCL2", "rs4586,", "CCL18", "rs14304,", "and", "IRF3", "rs2304205", "had", "univariate", "and", "multivariable", "correlations", "with", "PFS", "in", "KRAS", "mutant", "placenta", "growth", "factor", " ", "(PIGF)", "play", "a", "critical", "role", "in", "the", "polarization", "of", "M1/M2", "phenotypes", "and", "the", "recruitment", "of", "TAMs", "to", "tumor", "microenvironment.", "We", "therefore", "hypothesized", "that", "variations", "in", "genes", "involved", "in", "regulating", "TAMs", "may", "predict", "clinical", "outcomes", "of", "bevacizumab", "treatment", "in", "patients", "with", "metastatic", "colorectal", "cancer", "(mCRC)." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
TBK1 rs7486100 was significantly associated with overall survival in 95 KRAS wild-type patients of TRIBE cohort in univariate analysis and had a strong trend in multivariable analysis; furthermore, the association of the T allele was observed for progression-free survival (PFS) in both univariate and multivariable analyses in FIRE3-bevacizumab but not cetuximab cohort. CCL2 rs4586, CCL18 rs14304, and IRF3 rs2304205 had univariate and multivariable correlations with PFS in KRAS mutant placenta growth factor (PIGF) play a critical role in the polarization of M1/M2 phenotypes and the recruitment of TAMs to tumor microenvironment. We therefore hypothesized that variations in genes involved in regulating TAMs may predict clinical outcomes of bevacizumab treatment in patients with metastatic colorectal cancer (mCRC).
[ 2, 28847, 26570, 28839, 9029, 1982, 2567, 2458, 1956, 3399, 3298, 1922, 3002, 11083, 3576, 17, 2601, 2132, 1927, 14521, 1021, 4382, 1922, 9895, 2333, 1930, 2430, 43, 3206, 5045, 1922, 11327, 2333, 31, 3677, 16, 1920, 3279, 1927, 1920, 62, 5465, 1982, 2528, 1958, 4380, 17, 3294, 3298, 12, 11133, 13, 1922, 2321, 9895, 1930, 11327, 3247, 1922, 11105, 1010, 17, 15250, 2308, 2084, 19418, 4382, 18, 18280, 4366, 6803, 11617, 16, 10322, 3928, 4366, 24428, 14743, 16, 1930, 23827, 4366, 4553, 14743, 23368, 2430, 9895, 1930, 11327, 6100, 1956, 11133, 1922, 11083, 3606, 13752, 2905, 2991, 12, 5445, 1038, 13, 3918, 43, 4140, 2770, 1922, 1920, 10839, 1927, 8510, 19, 6056, 6568, 1930, 1920, 6067, 1927, 23775, 1942, 2798, 10236, 18, 2038, 2955, 7149, 1988, 6740, 1922, 2628, 3286, 1922, 6773, 23775, 2278, 5660, 2535, 3685, 1927, 15250, 2311, 1922, 2132, 1956, 6476, 7820, 2539, 12, 17379, 1030, 13, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
26416897
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
9691992
[ "A", "novel", "missense", "mutation", "and", "frameshift", "mutations", "in", "the", "type", "II", "receptor", "of", "transforming", "growth", "factor-beta", "gene", "in", "sporadic", "colon", "cancer", "with", "microsatellite", "instability." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
A novel missense mutation and frameshift mutations in the type II receptor of transforming growth factor-beta gene in sporadic colon cancer with microsatellite instability.
[ 2, 43, 4008, 13519, 3979, 1930, 21848, 3527, 1922, 1920, 2601, 2890, 3148, 1927, 13231, 2905, 2991, 17, 4666, 2359, 1922, 13088, 4120, 2539, 1956, 16069, 9557, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
21261604
[ "Childhood", "brain", "tumours", "may", "be", "due", "to", "germline", "bi-allelic", "mismatch", "repair", "(MMR)", "gene", "mutations", " ", "in", "MLH1", ",", "MSH2,", "MSH6", "or", "PMS2.", "These", "mutations", "MSH2", ",", "MSH6", " ", "or", "PMS2", ".", "These", "mutations", "can", "also", "lead", "to", "colorectal", "neoplasia", "and", "haematological", "malignancies.", "Here,", "we", "review", "this", "syndrome", "and", "present", "siblings", "with", "early-onset", "rectal", "adenoma", "and", "papillary", "glioneural", "brain", "tumour,", "respectively,", "due", "to", "novel", "germline", "bi-allelic", "PMS2", "mutations.", "Identification", "of", "MMR", "protein", "defects", "can", "lead", "to", "early", "diagnosis", "of", "this", "condition.", "In", "addition,", "assays", "for", "these", "defects", "may", "help", "to", "classify", "brain", "tumours", "for", "research", "protocols", "aimed", "at", "targeted", "therapies." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 1, 0, 0, 0, 0, 0, 0, 3, 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Childhood brain tumours may be due to germline bi-allelic mismatch repair (MMR) gene mutations in MLH1 , MSH2, MSH6 or PMS2. These mutations MSH2 , MSH6 or PMS2 . These mutations can also lead to colorectal neoplasia and haematological malignancies. Here, we review this syndrome and present siblings with early-onset rectal adenoma and papillary glioneural brain tumour, respectively, due to novel germline bi-allelic PMS2 mutations. Identification of MMR protein defects can lead to early diagnosis of this condition. In addition, assays for these defects may help to classify brain tumours for research protocols aimed at targeted therapies.
[ 2, 7238, 3068, 9313, 2278, 1998, 2810, 1942, 12237, 2273, 17, 13045, 10265, 5059, 12, 16744, 13, 2359, 3527, 1922, 25265, 16, 26693, 16, 19864, 1016, 2014, 13673, 1028, 18, 2144, 3527, 26693, 16, 19864, 1016, 2014, 13673, 1028, 18, 2144, 3527, 2112, 2222, 2949, 1942, 7820, 17773, 1930, 28691, 10672, 18, 3410, 16, 2038, 3043, 2052, 4741, 1930, 2481, 14715, 1956, 3120, 17, 4727, 11635, 16530, 1930, 15787, 6534, 2290, 2741, 3068, 6383, 16, 2763, 16, 2810, 1942, 4008, 12237, 2273, 17, 13045, 13673, 1028, 3527, 18, 4824, 1927, 16744, 2213, 6007, 2112, 2949, 1942, 3120, 3574, 1927, 2052, 2625, 18, 1922, 2459, 16, 4614, 1958, 2144, 6007, 2278, 4087, 1942, 14953, 3068, 9313, 1958, 2659, 6997, 6822, 2019, 5154, 6565, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 1, 0, 1, 2, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
24120286
[ "[Indications", "for", "prophylactic", "hysterectomy]." ]
[ 0, 0, 0, 0 ]
[Indications for prophylactic hysterectomy].
[ 2, 37, 11615, 1958, 14847, 19561, 39, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, -100 ]
17350669
[ "Fatty", "acid", "synthase", "overexpression", "in", "colorectal", "cancer", "is", "associated", "with", "microsatellite", "instability,", "independent", "of", "CpG", "island", "methylator", "phenotype." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
[ 2, 5934, 2687, 8921, 5616, 1922, 7820, 2539, 1977, 2458, 1956, 16069, 9557, 16, 3484, 1927, 9383, 10269, 4963, 3061, 4629, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
15946795
[ "Little", "is", "known", "about", "genetic", "risk", "factors", "for", "colorectal", "cancer.", "We", "assessed", "the", "association", "between", "polymorphisms", "polymorphisms", " ", "and", "risk", "of", "development", "of", "colorectal", "adenomas", "and", "colorectal", "cancer." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Little is known about genetic risk factors for colorectal cancer. We assessed the association between polymorphisms polymorphisms and risk of development of colorectal adenomas and colorectal cancer.
[ 2, 5082, 1977, 3171, 3001, 3299, 2565, 2790, 1958, 7820, 2539, 18, 2038, 3683, 1920, 3279, 2192, 8321, 8321, 1930, 2565, 1927, 2740, 1927, 7820, 16787, 1930, 7820, 2539, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
21128281
[ "In", "the", "majority", "of", "colorectal", "cancers", "(CRCs)", "under", "clinical", "suspicion", "for", "a", "hereditary", "cause,", "the", "disease-causing", "genetic", "factors", "are", "still", "to", "be", "discovered.", "To", "identify", "such", "genetic", "factors", "we", "stringently", "selected", "a", "discovery", "cohort", "of", "41", "CRC", "index", "patients", "with", "microsatellite-stable", "tumors.", "All", "patients", "were", "below", "40", "years", "of", "age", "at", "diagnosis", "and/or", "exhibited", "an", "overt", "family", "history.", "We", "employed", "genome-wide", "copy", "number", "profiling", "using", "high-resolution", "SNP", "arrays", "on", "germline", "DNA,", "which", "resulted", "in", "the", "identification", "of", "novel", "copy", "number", "variants", "(CNVs)", "in", "six", "patients", "(15%)", "encompassing,", "among", "others,", "the", "cadherin", "gene", "CDH18,", "the", "bone", "morphogenetic", "protein", "antagonist", "family", "gene", "GREM1,", "and", "the", "breakpoint", "cluster", "region", "gene", "BCR.", "In", "addition,", "two", "genomic", "deletions", "were", "encountered", "encompassing", "two", "microRNA", "genes,", "hsa-mir-491/KIAA1797", "and", "hsa-mir-646", "copy", "number", "variants", " ", "(", "CNVs", ")", "in", "six", "patients", "(15%)", "encompassing,", "among", "others,", "the", "cadherin", "gene", "CDH18", ",", "the", "bone", "morphogenetic", "protein", "antagonist", "family", "gene", "GREM1,", "and", "the", "breakpoint", "cluster", "region", "gene", "BCR.", "In", "addition,", "two", "genomic", "deletions", "were", "encountered", "encompassing", "two", "microRNA", "genes,", "hsa-mir-491", "/KIAA1797", "and", "hsa-mir-646/AK309218.", "None", "of", "these", "CNVs", "has", "previously", "been", "reported", "in", "relation", "to", "CRC", "predisposition", "in", "humans,", "nor", "were", "they", "encountered", "in", "large", "control", "cohorts", "(>1,600", "unaffected", "individuals).", "Since", "several", "of", "these", "newly", "identified", "candidate", "genes", "may", "be", "functionally", "linked", "to", "CRC", "development,", "our", "results", "illustrate", "the", "potential", "of", "this", "approach", "for", "the", "identification", "of", "novel", "candidate", "genes", "involved", "in", "CRC", "predisposition." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 15, 3, 4, 4, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 15, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
In the majority of colorectal cancers (CRCs) under clinical suspicion for a hereditary cause, the disease-causing genetic factors are still to be discovered. To identify such genetic factors we stringently selected a discovery cohort of 41 CRC index patients with microsatellite-stable tumors. All patients were below 40 years of age at diagnosis and/or exhibited an overt family history. We employed genome-wide copy number profiling using high-resolution SNP arrays on germline DNA, which resulted in the identification of novel copy number variants (CNVs) in six patients (15%) encompassing, among others, the cadherin gene CDH18, the bone morphogenetic protein antagonist family gene GREM1, and the breakpoint cluster region gene BCR. In addition, two genomic deletions were encountered encompassing two microRNA genes, hsa-mir-491/KIAA1797 and hsa-mir-646 copy number variants ( CNVs ) in six patients (15%) encompassing, among others, the cadherin gene CDH18 , the bone morphogenetic protein antagonist family gene GREM1, and the breakpoint cluster region gene BCR. In addition, two genomic deletions were encountered encompassing two microRNA genes, hsa-mir-491 /KIAA1797 and hsa-mir-646/AK309218. None of these CNVs has previously been reported in relation to CRC predisposition in humans, nor were they encountered in large control cohorts (>1,600 unaffected individuals). Since several of these newly identified candidate genes may be functionally linked to CRC development, our results illustrate the potential of this approach for the identification of novel candidate genes involved in CRC predisposition.
[ 2, 1922, 1920, 4827, 1927, 7820, 5717, 12, 8223, 1036, 13, 2441, 2535, 18419, 1958, 43, 16321, 3936, 16, 1920, 2573, 17, 7538, 3299, 2790, 2032, 3974, 1942, 1998, 8117, 18, 1942, 3512, 2427, 3299, 2790, 2038, 16801, 1954, 3790, 43, 7139, 4382, 1927, 4353, 8223, 3867, 2132, 1956, 16069, 17, 4700, 3861, 18, 2136, 2132, 1985, 4535, 3040, 2739, 1927, 2632, 2019, 3574, 1930, 19, 2014, 5065, 1925, 14702, 3416, 4403, 18, 2038, 5789, 3843, 17, 4743, 6983, 2529, 10156, 2193, 2149, 17, 4885, 6821, 10517, 1990, 12237, 2678, 16, 2154, 4306, 1922, 1920, 4824, 1927, 4008, 6983, 2529, 4936, 12, 20393, 13, 1922, 3798, 2132, 12, 2461, 9, 13, 17527, 16, 2706, 4991, 16, 1920, 8875, 2359, 23478, 1025, 16, 1920, 3622, 23359, 2213, 8151, 3416, 2359, 2705, 8012, 16, 1930, 1920, 24698, 4377, 3031, 2359, 10915, 18, 1922, 2459, 16, 2288, 4935, 10550, 1985, 11989, 17527, 2288, 14084, 2628, 16, 13273, 17, 3138, 17, 4343, 1009, 19, 8191, 5025, 25229, 1027, 1930, 13273, 17, 3138, 17, 4723, 1016, 6983, 2529, 4936, 12, 20393, 13, 1922, 3798, 2132, 12, 2461, 9, 13, 17527, 16, 2706, 4991, 16, 1920, 8875, 2359, 23478, 1025, 16, 1920, 3622, 23359, 2213, 8151, 3416, 2359, 2705, 8012, 16, 1930, 1920, 24698, 4377, 3031, 2359, 10915, 18, 1922, 2459, 16, 2288, 4935, 10550, 1985, 11989, 17527, 2288, 14084, 2628, 16, 13273, 17, 3138, 17, 4343, 1009, 19, 8191, 5025, 25229, 1027, 1930, 13273, 17, 3138, 17, 4723, 1016, 19, 4464, 26494, 4716, 1025, 18, 6046, 1927, 2144, 20393, 2258, 3024, 2252, 2568, 1922, 6147, 1942, 8223, 17757, 1922, 5209, 16, 3990, 1985, 2611, 11989, 1922, 3103, 2285, 8509, 12, 34, 21, 16, 8333, 10403, 3445, 13, 18, 3328, 2980, 1927, 2144, 7471, 2899, 6610, 2628, 2278, 1998, 9346, 4624, 1942, 8223, 2740, 16, 2342, 2274, 11197, 1920, 2889, 1927, 2052, 2998, 1958, 1920, 4824, 1927, 4008, 6610, 2628, 3286, 1922, 8223, 17757, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 15, 16, 16, 16, 16, 16, 3, 4, 4, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 15, 16, 16, 16, 16, 16, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
12530077
[ "Mucin-1", " ", "is", "expressed", "in", "a", "variety", "of", "colon", "carcinomas", "and", "Muc-1/", "DF3", " ", "promoters", "have", "been", "utilized", "to", "reduce", "systemic", "toxicity", "through", "specific", "gene", "expression.", "To", "overcome", "weak", "expression,", "which", "is", "much", "lower", "than", "the", "widely", "used", "cytomegalovirus-promoter", "(CMV),", "new", "adenoviral", "vectors", "containing", "a", "binary", "system", "of", "transgene", "amplification", "have", "been", "developed.", "The", "Muc-1", "/", "DF3", " ", "promoter", "was", "used", "to", "control", "the", "expression", "of", "a", "Gal4", "VP16", "fusion", "protein.", "This", "vector", "also", "contained", "Gal4", "binding", "sites", "enabling", "the", "fusion", "protein", "to", "act", "as", "a", "transactivator,", "inducing", "transgene", "expression", "within", "the", "same", "construct.", "Mucin-1", "expression", "was", "analyzed", "in", "a", "variety", "of", "colon", "cancer", "cell", "lines.", "After", "infection", "with", "recombinant", "adenoviruses,", "transgene", "expression", "was", "quantified", "using", "the", "luciferase", "system.", "Integration", "of", "the", "Gal4", "VP16", "VP16", " ", "fusion", "protein.", "This", "vector", "also", "contained", "Gal4", "binding", "sites", "enabling", "the", "fusion", "protein", "to", "act", "as", "a", "transactivator,", "inducing", "transgene", "expression", "within", "the", "same", "construct.", "Mucin-1", "expression", "was", "analyzed", "in", "a", "variety", "of", "colon", "cancer", "cell", "lines.", "After", "infection", "with", "recombinant", "adenoviruses,", "transgene", "expression", "was", "quantified", "using", "the", "luciferase", "system.", "Integration", "of", "the", "Gal4VP16-binary", "resulted", "in", "an", "up", "to", "250-fold", "increase", "of", "Muc-1/", "DF3", "Gal4", "VP16-binary", "resulted", "in", "an", "up", "to", "250-fold", "increase", "of", "Muc-1/DF3-specific", "gene", "expression.", "In", "mucin-positive", "cell", "lines", "utilizing", "this", "amplified", "Muc-1", "Muc-1", "/DF3-specific", "gene", "expression.", "In", "mucin-positive", "cell", "lines", "utilizing", "this", "amplified", "Muc-1/", "DF3", " ", "promoter,", "expression", "was", "up", "to", "590-fold", "higher", "as", "compared", "to", "the", "CMV-promoter.", "Western", "blot", "detected", "the", "presence", "of", "Gal4", "VP16", " ", "in", "infected", "muc-1-positive", "but", "not-negative", "cell", "lines.", "These", "new", "adenoviral", "vectors", "combing", "highly", "efficient", "and", "specific", "transgene", "expression", "and", "will", "contribute", "to", "the", "safety", "and", "efficacy", "of", "experimental", "approaches", "in", "cancer", "gene", "therapy." ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Mucin-1 is expressed in a variety of colon carcinomas and Muc-1/ DF3 promoters have been utilized to reduce systemic toxicity through specific gene expression. To overcome weak expression, which is much lower than the widely used cytomegalovirus-promoter (CMV), new adenoviral vectors containing a binary system of transgene amplification have been developed. The Muc-1 / DF3 promoter was used to control the expression of a Gal4 VP16 fusion protein. This vector also contained Gal4 binding sites enabling the fusion protein to act as a transactivator, inducing transgene expression within the same construct. Mucin-1 expression was analyzed in a variety of colon cancer cell lines. After infection with recombinant adenoviruses, transgene expression was quantified using the luciferase system. Integration of the Gal4 VP16 VP16 fusion protein. This vector also contained Gal4 binding sites enabling the fusion protein to act as a transactivator, inducing transgene expression within the same construct. Mucin-1 expression was analyzed in a variety of colon cancer cell lines. After infection with recombinant adenoviruses, transgene expression was quantified using the luciferase system. Integration of the Gal4VP16-binary resulted in an up to 250-fold increase of Muc-1/ DF3 Gal4 VP16-binary resulted in an up to 250-fold increase of Muc-1/DF3-specific gene expression. In mucin-positive cell lines utilizing this amplified Muc-1 Muc-1 /DF3-specific gene expression. In mucin-positive cell lines utilizing this amplified Muc-1/ DF3 promoter, expression was up to 590-fold higher as compared to the CMV-promoter. Western blot detected the presence of Gal4 VP16 in infected muc-1-positive but not-negative cell lines. These new adenoviral vectors combing highly efficient and specific transgene expression and will contribute to the safety and efficacy of experimental approaches in cancer gene therapy.
[ 2, 14455, 17, 21, 1977, 3198, 1922, 43, 5386, 1927, 4120, 10691, 1930, 3422, 17, 21, 19, 8122, 1010, 9026, 2162, 2252, 7079, 1942, 4412, 5510, 5532, 2596, 2487, 2359, 2294, 18, 1942, 9063, 5015, 2294, 16, 2154, 1977, 4186, 2826, 2254, 1920, 5673, 2251, 21110, 17, 4465, 12, 10583, 13, 16, 2814, 22870, 7623, 3165, 43, 9921, 2433, 1927, 11199, 6584, 2162, 2252, 3530, 18, 1920, 3422, 17, 21, 19, 8122, 1010, 4465, 1982, 2251, 1942, 2285, 1920, 2294, 1927, 43, 12617, 29231, 5289, 2213, 18, 2052, 4580, 2222, 5543, 12617, 2743, 3402, 12180, 1920, 5289, 2213, 1942, 4033, 1966, 43, 27092, 3061, 16, 7834, 11199, 2294, 2651, 1920, 2841, 6377, 18, 14455, 17, 21, 2294, 1982, 3265, 1922, 43, 5386, 1927, 4120, 2539, 2024, 3557, 18, 2256, 2909, 1956, 5752, 13354, 1918, 16, 11199, 2294, 1982, 6395, 2193, 1920, 7362, 2433, 18, 7122, 1927, 1920, 12617, 29231, 29231, 5289, 2213, 18, 2052, 4580, 2222, 5543, 12617, 2743, 3402, 12180, 1920, 5289, 2213, 1942, 4033, 1966, 43, 27092, 3061, 16, 7834, 11199, 2294, 2651, 1920, 2841, 6377, 18, 14455, 17, 21, 2294, 1982, 3265, 1922, 43, 5386, 1927, 4120, 2539, 2024, 3557, 18, 2256, 2909, 1956, 5752, 13354, 1918, 16, 11199, 2294, 1982, 6395, 2193, 1920, 7362, 2433, 18, 7122, 1927, 1920, 12617, 23247, 3672, 17, 9921, 4306, 1922, 1925, 2353, 1942, 6330, 17, 3728, 2760, 1927, 3422, 17, 21, 19, 8122, 1010, 12617, 29231, 17, 9921, 4306, 1922, 1925, 2353, 1942, 6330, 17, 3728, 2760, 1927, 3422, 17, 21, 19, 8122, 1010, 17, 2487, 2359, 2294, 18, 1922, 14455, 17, 2843, 2024, 3557, 10232, 2052, 7006, 3422, 17, 21, 3422, 17, 21, 19, 8122, 1010, 17, 2487, 2359, 2294, 18, 1922, 14455, 17, 2843, 2024, 3557, 10232, 2052, 7006, 3422, 17, 21, 19, 8122, 1010, 4465, 16, 2294, 1982, 2353, 1942, 24886, 17, 3728, 2580, 1966, 2452, 1942, 1920, 10583, 17, 4465, 18, 4540, 4918, 3330, 1920, 2990, 1927, 12617, 29231, 1922, 4014, 3422, 17, 21, 17, 2843, 2308, 2084, 17, 3136, 2024, 3557, 18, 2144, 2814, 22870, 7623, 2898, 1941, 3626, 5807, 1930, 2487, 11199, 2294, 1930, 2832, 4672, 1942, 1920, 5407, 1930, 4348, 1927, 3599, 4895, 1922, 2539, 2359, 3181, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
9609758
[ "An", "absence", "or", "a", "presence", "of", "mutated", "transforming", "growth", "factor", "(TGF)-beta", "receptors", "is", "a", "possible", "hypothesis", "explaining", "the", "resistance", "of", "cancer", "cells", "to", "the", "growth-inhibitory", "effect", "of", "TGF-beta", "mutated", " ", "transforming", "growth", "factor", "(TGF)-beta", "receptors", "is", "a", "possible", "hypothesis", "explaining", "the", "resistance", "of", "cancer", "cells", "to", "the", "growth-inhibitory", "effect", "of", "TGF-beta.", "Mutations", "involving", "microsatellite-like", "regions", "of", "the", "type", "II", "TGF-beta", "receptor", "have", "been", "described", "in", "subgroups", "of", "colorectal", "cancers.", "The", "aim", "of", "this", "study", "was", "to", "investigate", "the", "expression", "and", "distribution", "of", "TGF-beta", "receptors", "transforming", "growth", "factor", "(TGF)-beta", "receptors", " ", "is", "a", "possible", "hypothesis", "explaining", "the", "resistance", "of", "cancer", "cells", "to", "the", "growth-inhibitory", "effect", "of", "TGF-beta.", "Mutations", "involving", "microsatellite-like", "regions", "of", "the", "type", "II", "TGF-beta", "receptor", "have", "been", "described", "in", "subgroups", "of", "colorectal", "cancers.", "The", "aim", "of", "this", "study", "was", "to", "investigate", "the", "expression", "and", "distribution", "of", "TGF-beta", "receptors", "in", "sporadic", "colorectal", "cancers", "and", "normal", "tissues." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
An absence or a presence of mutated transforming growth factor (TGF)-beta receptors is a possible hypothesis explaining the resistance of cancer cells to the growth-inhibitory effect of TGF-beta mutated transforming growth factor (TGF)-beta receptors is a possible hypothesis explaining the resistance of cancer cells to the growth-inhibitory effect of TGF-beta. Mutations involving microsatellite-like regions of the type II TGF-beta receptor have been described in subgroups of colorectal cancers. The aim of this study was to investigate the expression and distribution of TGF-beta receptors transforming growth factor (TGF)-beta receptors is a possible hypothesis explaining the resistance of cancer cells to the growth-inhibitory effect of TGF-beta. Mutations involving microsatellite-like regions of the type II TGF-beta receptor have been described in subgroups of colorectal cancers. The aim of this study was to investigate the expression and distribution of TGF-beta receptors in sporadic colorectal cancers and normal tissues.
[ 2, 1925, 3905, 2014, 43, 2990, 1927, 8336, 13231, 2905, 2991, 12, 5525, 13, 17, 4666, 4086, 1977, 43, 3216, 4676, 13850, 1920, 3554, 1927, 2539, 2094, 1942, 1920, 2905, 17, 5431, 2495, 1927, 5525, 17, 4666, 8336, 13231, 2905, 2991, 12, 5525, 13, 17, 4666, 4086, 1977, 43, 3216, 4676, 13850, 1920, 3554, 1927, 2539, 2094, 1942, 1920, 2905, 17, 5431, 2495, 1927, 5525, 17, 4666, 18, 3527, 5884, 16069, 17, 3189, 3451, 1927, 1920, 2601, 2890, 5525, 17, 4666, 3148, 2162, 2252, 2910, 1922, 9161, 1927, 7820, 5717, 18, 1920, 3774, 1927, 2052, 2161, 1982, 1942, 4482, 1920, 2294, 1930, 3282, 1927, 5525, 17, 4666, 4086, 13231, 2905, 2991, 12, 5525, 13, 17, 4666, 4086, 1977, 43, 3216, 4676, 13850, 1920, 3554, 1927, 2539, 2094, 1942, 1920, 2905, 17, 5431, 2495, 1927, 5525, 17, 4666, 18, 3527, 5884, 16069, 17, 3189, 3451, 1927, 1920, 2601, 2890, 5525, 17, 4666, 3148, 2162, 2252, 2910, 1922, 9161, 1927, 7820, 5717, 18, 1920, 3774, 1927, 2052, 2161, 1982, 1942, 4482, 1920, 2294, 1930, 3282, 1927, 5525, 17, 4666, 4086, 1922, 13088, 7820, 5717, 1930, 2791, 3878, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 1, 2, 2, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
15946795
[ "Little", "is", "known", "about", "genetic", "risk", "factors", "for", "colorectal", "cancer.", "We", "assessed", "the", "association", "between", "polymorphisms", "in", "two", "genes", "involved", "in", "DNA", "repair", "of", "oxidative", "stress,", "GPX", "and", "OGG1,", "and", "risk", "of", "colorectal", "carcinoma", "or", "adenomas.", "We", "studied", "166", "cases", "with", "adenocarcinoma,", "974", "with", "adenomas", "and", "397", "controls", "recruited", "from", "the", "Norwegian", "cohort", "NORCCAP.", "No", "associations", "were", "found", "between", "the", "polymorphism", "GPX", "Pro198Leu", "and", "risk", "of", "colorectal", "adenomas", "or", "carcinomas.", "Carriers", "of", "the", "variant", "allele", "OGG1", "Ser326Cys", "polymorphism", "polymorphism", "Ser326Cys", " ", "polymorphisms", "and", "risk", "of", "development", "of", "colorectal", "adenomas", "and", "colorectal", "cancer." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 13, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Little is known about genetic risk factors for colorectal cancer. We assessed the association between polymorphisms in two genes involved in DNA repair of oxidative stress, GPX and OGG1, and risk of colorectal carcinoma or adenomas. We studied 166 cases with adenocarcinoma, 974 with adenomas and 397 controls recruited from the Norwegian cohort NORCCAP. No associations were found between the polymorphism GPX Pro198Leu and risk of colorectal adenomas or carcinomas. Carriers of the variant allele OGG1 Ser326Cys polymorphism polymorphism Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer.
[ 2, 5082, 1977, 3171, 3001, 3299, 2565, 2790, 1958, 7820, 2539, 18, 2038, 3683, 1920, 3279, 2192, 8321, 1922, 2288, 2628, 3286, 1922, 2678, 5059, 1927, 5163, 3071, 16, 23151, 1930, 17395, 9114, 16, 1930, 2565, 1927, 7820, 5373, 2014, 16787, 18, 2038, 3942, 15255, 2919, 1956, 9573, 16, 5749, 1006, 1956, 16787, 1930, 27671, 3562, 6878, 2037, 1920, 21190, 4382, 3990, 2437, 2026, 18, 2239, 5253, 1985, 2435, 2192, 1920, 8218, 23151, 1965, 25016, 1952, 1032, 1930, 2565, 1927, 7820, 16787, 2014, 10691, 18, 8974, 1927, 1920, 6031, 5465, 17395, 9114, 2375, 6763, 20316, 2012, 8218, 8218, 2375, 6763, 20316, 2012, 8321, 1930, 2565, 1927, 2740, 1927, 7820, 16787, 1930, 7820, 2539, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 13, 14, 14, 14, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
12534642
[ "In", "114", "samples,", "the", "most", "frequent", "CYP1A2", "SNPs", "were", "1545T-->C", "(38.2%", "of", "tested", "chromosomes),", "-164A-->C", "(CYP1A2*1F,", "33.3%)", "and", "-2464T-->delT", "(CYP1A2*1D,", "4.82%).", "The", "SNPs", "were", "in", "linkage", "disequilibrium:", "the", "most", "frequent", "constellations", "were", "found", "to", "be", "-3858G/-2464T/-740T/-164A/63C/1545T", "(61.8%),", "-3858G/-2464T/-740T/-164C/63C/1545C", "(33.3%),", "and", "-3858G/-2464delT/-740T/-164A/63C/1545C", "(3.51%),", "with", "no", "significant", "frequency", "differences", "between", "cases", "and", "controls.", "In", "the", "phenotype", "analysis,", "lower", "caffeine", "metabolic", "ratios", "were", "detected", "in", "cases", "than", "in", "controls.", "This", "was", "significant", "in", "smokers", "(n", "=", "14,", "P", "=", "0.020),", "and", "in", "a", "subgroup", "of", "15", "matched", "case-control", "pairs", "(P", "=", "0.007),", "but", "it", "was", "not", "significant", "in", "nonsmokers", "(n", "=", "100,", "P", "=", "0.39).", "There", "was", "no", "detectable", "association", "between", "CYP1A2", "SNPs", ")", "of", "the", "cytochrome", "P450", "enzyme", "1A2", "gene", "(CYP1A2)", "have", "been", "reported.", "Here,", "frequencies,", "linkage", "disequilibrium", "and", "phenotypic", "consequences", "of", "six", "SNPs", "are", "described." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
In 114 samples, the most frequent CYP1A2 SNPs were 1545T-->C (38.2% of tested chromosomes), -164A-->C (CYP1A2*1F, 33.3%) and -2464T-->delT (CYP1A2*1D, 4.82%). The SNPs were in linkage disequilibrium: the most frequent constellations were found to be -3858G/-2464T/-740T/-164A/63C/1545T (61.8%), -3858G/-2464T/-740T/-164C/63C/1545C (33.3%), and -3858G/-2464delT/-740T/-164A/63C/1545C (3.51%), with no significant frequency differences between cases and controls. In the phenotype analysis, lower caffeine metabolic ratios were detected in cases than in controls. This was significant in smokers (n = 14, P = 0.020), and in a subgroup of 15 matched case-control pairs (P = 0.007), but it was not significant in nonsmokers (n = 100, P = 0.39). There was no detectable association between CYP1A2 SNPs ) of the cytochrome P450 enzyme 1A2 gene (CYP1A2) have been reported. Here, frequencies, linkage disequilibrium and phenotypic consequences of six SNPs are described.
[ 2, 1922, 11296, 2785, 16, 1920, 2501, 6439, 6120, 23750, 6084, 1985, 14396, 1015, 1031, 17, 17, 34, 45, 12, 3738, 18, 22, 9, 1927, 3620, 8597, 13, 16, 17, 15170, 1019, 17, 17, 34, 45, 12, 6120, 23750, 14, 14078, 16, 3401, 18, 23, 9, 13, 1930, 17, 21141, 1006, 1031, 17, 17, 34, 17496, 12, 6120, 23750, 14, 8046, 16, 24, 18, 6175, 9, 13, 18, 1920, 6084, 1985, 1922, 8611, 19264, 30, 1920, 2501, 6439, 4713, 30439, 1036, 1985, 2435, 1942, 1998, 17, 25800, 1025, 1029, 19, 17, 21141, 1006, 1031, 19, 17, 5446, 1008, 1031, 19, 17, 15170, 1019, 19, 4968, 1030, 19, 14396, 1015, 1031, 12, 5473, 18, 28, 9, 13, 16, 17, 25800, 1025, 1029, 19, 17, 21141, 1006, 1031, 19, 17, 5446, 1008, 1031, 19, 17, 15170, 1030, 19, 4968, 1030, 19, 14396, 20118, 12, 3401, 18, 23, 9, 13, 16, 1930, 17, 25800, 1025, 1029, 19, 17, 21141, 28660, 9551, 19, 17, 5446, 1008, 1031, 19, 17, 15170, 1019, 19, 4968, 1030, 19, 14396, 20118, 12, 23, 18, 4892, 9, 13, 16, 1956, 2239, 2228, 3528, 2886, 2192, 2919, 1930, 3562, 18, 1922, 1920, 4629, 2333, 16, 2826, 14119, 4487, 5835, 1985, 3330, 1922, 2919, 2254, 1922, 3562, 18, 2052, 1982, 2228, 1922, 8112, 12, 56, 33, 2607, 16, 58, 33, 20, 18, 18773, 13, 16, 1930, 1922, 43, 6200, 1927, 2461, 5992, 3087, 17, 2285, 5803, 12, 58, 33, 20, 18, 13298, 13, 16, 2308, 2176, 1982, 2084, 2228, 1922, 28500, 12, 56, 33, 2813, 16, 58, 33, 20, 18, 3886, 13, 18, 2276, 1982, 2239, 7398, 3279, 2192, 6120, 23750, 6084, 13, 1927, 1920, 9387, 12088, 4113, 5123, 1028, 2359, 12, 6120, 23750, 13, 2162, 2252, 2568, 18, 3410, 16, 6458, 16, 8611, 19264, 1930, 8189, 7080, 1927, 3798, 6084, 2032, 2910, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
25374237
[ "The", "relation", "between", "colon", "cancer", "and", "survivin", "-31", "G/C", "(rs9904341),", "-241", "C/T", "(rs17878467)", "and", "-625", "C/G", "(rs8073069)", "polymorphism", "in", "promotor", "site", "of", "survivin", "gene", "associated", "with", "apoptosis", "was", "investigated", "using", "the", "polymerase", "chain", "reaction-restriction", "fragment", "length", "polymorphism", "(PCR-RFLP)", "method." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
The relation between colon cancer and survivin -31 G/C (rs9904341), -241 C/T (rs17878467) and -625 C/G (rs8073069) polymorphism in promotor site of survivin gene associated with apoptosis was investigated using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.
[ 2, 1920, 6147, 2192, 4120, 2539, 1930, 17259, 17, 3470, 49, 19, 45, 12, 4366, 6576, 14743, 4857, 1009, 13, 16, 17, 21616, 45, 19, 62, 12, 4366, 24761, 7950, 7772, 1027, 13, 1930, 17, 23474, 45, 19, 49, 12, 4366, 4476, 8966, 14265, 1026, 13, 8218, 1922, 4212, 1924, 3200, 1927, 17259, 2359, 2458, 1956, 4091, 1982, 3845, 2193, 1920, 6479, 4659, 3227, 17, 7587, 5302, 3471, 8218, 12, 3343, 17, 22393, 13, 2417, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
22810479
[ ":", "Overall", "K-ras", "gene", "mutations", "K-ras", "K-ras", " ", "gene", "mutation", "a", "prognostic", "factor", "for", "colorectal", "cancer:", "a", "systematic", "review", "and", "meta-analysis.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 3, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
: Overall K-ras gene mutations K-ras K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis. ## BACKGROUND
[ 2, 30, 3399, 53, 17, 6520, 2359, 3527, 53, 17, 6520, 53, 17, 6520, 2359, 3979, 43, 6750, 2991, 1958, 7820, 2539, 30, 43, 5614, 3043, 1930, 5880, 17, 2333, 18, 7, 7, 3872, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 3, 1, 2, 2, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
10822375
[ "Somatic", "mutation", "of", "hPMS2", "as", "a", "possible", "cause", "of", "sporadic", "human", "colon", "cancer", "with", "microsatellite", "instability." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability.
[ 2, 8548, 3979, 1927, 4688, 2800, 1028, 1966, 43, 3216, 3936, 1927, 13088, 2616, 4120, 2539, 1956, 16069, 9557, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
24196785
[ "##", "CONCLUSION" ]
[ 0, 0 ]
## CONCLUSION
[ 2, 7, 7, 4180, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
26925673
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
24196785
[ "We", "conducted", "cell", "proliferation", "and", "invasion", "assays", "using", "colorectal", "cancer", "cell", "lines", "transfected", "with", "PVT-1siRNA", "or", "negative", "control", "siRNA.", "Gene", "expression", "microarray", "analyses", "on", "these", "cell", "lines", "were", "also", "carried", "out", "to", "investigate", "the", "molecular", "function", "of", "PVT-1.", "Further,", "we", "investigated", "the", "impact", "of", "PVT-1", " ", "expression", "on", "the", "prognosis", "of", "164", "colorectal", "cancer", "patients", "by", "qRT-PCR." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We conducted cell proliferation and invasion assays using colorectal cancer cell lines transfected with PVT-1siRNA or negative control siRNA. Gene expression microarray analyses on these cell lines were also carried out to investigate the molecular function of PVT-1. Further, we investigated the impact of PVT-1 expression on the prognosis of 164 colorectal cancer patients by qRT-PCR.
[ 2, 2038, 3609, 2024, 4031, 1930, 6254, 4614, 2193, 7820, 2539, 2024, 3557, 5176, 1956, 5774, 1031, 17, 18939, 1996, 2175, 2014, 3136, 2285, 5929, 18, 2359, 2294, 7850, 3247, 1990, 2144, 2024, 3557, 1985, 2222, 4371, 2397, 1942, 4482, 1920, 3272, 2347, 1927, 5774, 1031, 17, 21, 18, 2520, 16, 2038, 3845, 1920, 3829, 1927, 5774, 1031, 17, 21, 2294, 1990, 1920, 6573, 1927, 15170, 7820, 2539, 2132, 2007, 10002, 17, 3343, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
8709782
[ "Between", "1956", "and", "mid-1995,", "225", "patients", "registered", "at", "the", "Netherlands", "Polyposis", "Registry", "had", "undergone", "IRA.", "In", "87", "of", "them,", "a", "pathogenetic", "mutation", "was", "detected.", "72", "patients", "had", "a", "mutation", "located", "before", "codon", "1250", "and", "15", "patients", "after", "this", "codon.", "The", "cumulative", "risk", "of", "rectal", "cancer", "20", "years", "after", "surgery", "was", "12%,", "and", "at", "that", "time", "42%", "had", "undergone", "rectal", "excision.", "The", "risk", "of", "secondary", "surgery", "was", "higher", "in", "patients", "with", "mutations", "in", "the", "region", "after", "codon", "1250", "than", "in", "patients", "with", "mutations", "before", "this", "codon", "(relative", "risk", "2.7,", "p", "<", "0.05)." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Between 1956 and mid-1995, 225 patients registered at the Netherlands Polyposis Registry had undergone IRA. In 87 of them, a pathogenetic mutation was detected. 72 patients had a mutation located before codon 1250 and 15 patients after this codon. The cumulative risk of rectal cancer 20 years after surgery was 12%, and at that time 42% had undergone rectal excision. The risk of secondary surgery was higher in patients with mutations in the region after codon 1250 than in patients with mutations before this codon (relative risk 2.7, p < 0.05).
[ 2, 2192, 16030, 1016, 1930, 3953, 17, 6719, 16, 16056, 2132, 10012, 2019, 1920, 11449, 28641, 10557, 2430, 12299, 3166, 1019, 18, 1922, 5783, 1927, 3581, 16, 43, 7055, 3023, 3979, 1982, 3330, 18, 4395, 2132, 2430, 43, 3979, 4810, 3119, 8905, 7151, 1008, 1930, 2461, 2132, 2256, 2052, 8905, 18, 1920, 8274, 2565, 1927, 11635, 2539, 2036, 2739, 2256, 3782, 1982, 2369, 9, 16, 1930, 2019, 1988, 2367, 3858, 9, 2430, 12299, 11635, 10940, 18, 1920, 2565, 1927, 4067, 3782, 1982, 2580, 1922, 2132, 1956, 3527, 1922, 1920, 3031, 2256, 8905, 7151, 1008, 2254, 1922, 2132, 1956, 3527, 3119, 2052, 8905, 12, 3338, 2565, 22, 18, 27, 16, 58, 32, 20, 18, 2914, 13, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
19706845
[ "##", "METHODS" ]
[ 0, 0 ]
## METHODS
[ 2, 7, 7, 2860, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
24435063
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
22899730
[ "##", "METHODS" ]
[ 0, 0 ]
## METHODS
[ 2, 7, 7, 2860, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
9609758
[ "Both", "receptors", "were", "overexpressed", "in", "tumors", "compared", "with", "normal", "samples.", "There", "was", "a", "relationship", "between", "the", "abundance", "of", "type", "II", "receptor", "expression", "and", "the", "degree", "of", "differentiation", "of", "the", "tumors", "but", "not", "the", "Dukes'", "staging", "or", "the", "localization", "of", "the", "neoplasias.", "No", "mutation", "was", "observed", "in", "the", "microsatellite-like", "regions", "of", "receptor", "II", "TGF", ")-beta", "receptors", "is", "a", "possible", "hypothesis", "explaining", "the", "resistance", "of", "cancer", "cells", "to", "the", "growth-inhibitory", "effect", "of", "TGF-beta.", "Mutations", " ", "involving", "microsatellite-like", "regions", "of", "the", "type", "II", "TGF-beta", "receptor", " ", "have", "been", "described", "in", "subgroups", "of", "colorectal", "cancers.", "The", "aim", "of", "this", "study", "was", "to", "investigate", "the", "expression", "and", "distribution", "of", "TGF-beta", "receptors", "in", "sporadic", "colorectal", "cancers", "and", "normal", "tissues." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Both receptors were overexpressed in tumors compared with normal samples. There was a relationship between the abundance of type II receptor expression and the degree of differentiation of the tumors but not the Dukes' staging or the localization of the neoplasias. No mutation was observed in the microsatellite-like regions of receptor II TGF )-beta receptors is a possible hypothesis explaining the resistance of cancer cells to the growth-inhibitory effect of TGF-beta. Mutations involving microsatellite-like regions of the type II TGF-beta receptor have been described in subgroups of colorectal cancers. The aim of this study was to investigate the expression and distribution of TGF-beta receptors in sporadic colorectal cancers and normal tissues.
[ 2, 2321, 4086, 1985, 10593, 1922, 3861, 2452, 1956, 2791, 2785, 18, 2276, 1982, 43, 3303, 2192, 1920, 6232, 1927, 2601, 2890, 3148, 2294, 1930, 1920, 4647, 1927, 4155, 1927, 1920, 3861, 2308, 2084, 1920, 26101, 1036, 11, 12183, 2014, 1920, 5363, 1927, 1920, 17773, 1036, 18, 2239, 3979, 1982, 2528, 1922, 1920, 16069, 17, 3189, 3451, 1927, 3148, 2890, 5525, 13, 17, 4666, 4086, 1977, 43, 3216, 4676, 13850, 1920, 3554, 1927, 2539, 2094, 1942, 1920, 2905, 17, 5431, 2495, 1927, 5525, 17, 4666, 18, 3527, 5884, 16069, 17, 3189, 3451, 1927, 1920, 2601, 2890, 5525, 17, 4666, 3148, 2162, 2252, 2910, 1922, 9161, 1927, 7820, 5717, 18, 1920, 3774, 1927, 2052, 2161, 1982, 1942, 4482, 1920, 2294, 1930, 3282, 1927, 5525, 17, 4666, 4086, 1922, 13088, 7820, 5717, 1930, 2791, 3878, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
9841584
[ "##", "PATIENTS" ]
[ 0, 0 ]
## PATIENTS
[ 2, 7, 7, 2132, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
8709782
[ "##", "FINDINGS" ]
[ 0, 0 ]
## FINDINGS
[ 2, 7, 7, 3056, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
23603433
[ "Specific", "patterns", "of", "genomic", "aberrations", "have", "been", "associated", "with", "different", "types", "of", "malignancies.", "In", "colorectal", "cancer,", "losses", "of", "chromosome", "arm", "8p", "and", "gains", "of", "chromosome", "arm", "8q", "are", "among", "the", "most", "common", "chromosomal", "rearrangements,", "suggesting", "that", "the", "centromeric", "portion", "of", "chromosome", "8", "is", "particularly", "sensitive", "to", "breakage.", "Genomic", "alterations", "PRKDC", "CEBPD", " ", "and", "PRKDC", "genes", "in", "colorectal", "cancer." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
Specific patterns of genomic aberrations have been associated with different types of malignancies. In colorectal cancer, losses of chromosome arm 8p and gains of chromosome arm 8q are among the most common chromosomal rearrangements, suggesting that the centromeric portion of chromosome 8 is particularly sensitive to breakage. Genomic alterations PRKDC CEBPD and PRKDC genes in colorectal cancer.
[ 2, 2487, 4147, 1927, 4935, 16303, 2162, 2252, 2458, 1956, 2413, 3584, 1927, 10672, 18, 1922, 7820, 2539, 16, 11783, 1927, 5597, 6011, 28, 1034, 1930, 13241, 1927, 5597, 6011, 28, 1055, 2032, 2706, 1920, 2501, 3059, 9220, 13955, 16, 3783, 1988, 1920, 25790, 7717, 1927, 5597, 28, 1977, 4443, 4532, 1942, 25816, 18, 4935, 5996, 22615, 11385, 5827, 3846, 1007, 1930, 22615, 11385, 2628, 1922, 7820, 2539, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 4, 1, 2, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
22810479
[ ":", "We", "searched", "PubMed,", "Embase,", "and", "the", "Cochrane", "databases", "from", "January", "1992", "to", "November", "2011." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
: We searched PubMed, Embase, and the Cochrane databases from January 1992 to November 2011.
[ 2, 30, 2038, 11415, 13093, 16, 18319, 16, 1930, 1920, 13917, 8506, 2037, 8555, 8348, 1942, 12832, 3750, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
24196785
[ "We", "conducted", "cell", "proliferation", "and", "invasion", "assays", "using", "colorectal", "cancer", "cell", "lines", "transfected", "with", "PVT-1", "Amplification", " ", "of", "PVT-1", "is", "involved", "in", "poor", "prognosis", "via", "apoptosis", "inhibition", "in", "colorectal", "cancers.", "\n\n\n", "##", "BACKGROUND" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
We conducted cell proliferation and invasion assays using colorectal cancer cell lines transfected with PVT-1 Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. ## BACKGROUND
[ 2, 2038, 3609, 2024, 4031, 1930, 6254, 4614, 2193, 7820, 2539, 2024, 3557, 5176, 1956, 5774, 1031, 17, 21, 6584, 1927, 5774, 1031, 17, 21, 1977, 3286, 1922, 3930, 6573, 3454, 4091, 3523, 1922, 7820, 5717, 18, 7, 7, 3872, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
12534642
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
26416897
[ "##", "CONCLUSIONS" ]
[ 0, 0 ]
## CONCLUSIONS
[ 2, 7, 7, 4355, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
26302849
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
9731891
[ "##", "RESULTS" ]
[ 0, 0 ]
## RESULTS
[ 2, 7, 7, 2274, 3 ]
[ 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, -100 ]
1347643
[ "Carcinogenesis", "is", "a", "multistage", "process", "that", "has", "been", "characterized", "both", "by", "the", "activation", "of", "cellular", "oncogenes", "and", "by", "the", "loss", "of", "function", "of", "tumor", "suppressor", "genes.", "Colorectal", "cancer", "has", "been", "associated", "with", "the", "activation", "of", "ras", "oncogenes", "and", "with", "the", "deletion", "of", "multiple", "chromosomal", "regions", "including", "chromosomes", "5q,", "17p,", "and", "18q.", "Such", "chromosome", "loss", "is", "often", "suggestive", "of", "the", "deletion", "or", "loss", "of", "function", "of", "tumor", "suppressor", "genes.", "The", "candidate", "tumor", "suppressor", "genes", "from", "these", "regions", "are,", "respectively,", "MCC", "and/or", "APC,", "p53,", "and", "DCC.", "In", "order", "to", "further", "our", "understanding", "of", "the", "molecular", "and", "genetic", "mechanisms", "involved", "in", "tumor", "progression", "and,", "thereby,", "of", "normal", "cell", "growth,", "it", "is", "important", "to", "determine", "whether", "defects", "in", "one", "or", "more", "of", "these", "loci", "contribute", "functionally", "in", "the", "progression", "to", "malignancy", "in", "colorectal", "cancer", "and", "whether", "correction", "of", "any", "of", "these", "defects", "restores", "normal", "growth", "control", "in", "vitro", "and", "in", "vivo.", "To", "address", "this", "question,", "we", "have", "utilized", "the", "technique", "of", "microcell-mediated", "chromosome", "transfer", "to", "introduce", "normal", "human", "chromosomes", "5,", "17,", "and", "18", "individually", "into", "recipient", "colorectal", "cancer", "cells.", "Additionally,", "chromosome", "15", "was", "introduced", "into", "SW480", "cells", "as", "an", "irrelevant", "control", "chromosome.", "While", "the", "introduction", "of", "chromosome", "17", "into", "the", "tumorigenic", "colorectal", "cell", "line", "SW480", "yielded", "no", "viable", "clones,", "cell", "lines", "were", "established", "after", "the", "introduction", "of", "chromosomes", "15,", "5,", "and", "18.", "Hybrids", "containing", "chromosome", "18", "are", "morphologically", "similar", "to", "the", "parental", "line,", "whereas", "those", "containing", "chromosome", "5", "are", "morphologically", "distinct", "from", "the", "parental", "cell", "line,", "being", "small,", "polygonal,", "and", "tightly", "packed.", "SW480-chromosome", "5", "hybrids", "are", "strongly", "suppressed", "for", "tumorigenicity,", "while", "SW480-chromosome", "18", "hybrids", "produce", "slowly", "growing", "tumors", "in", "some", "of", "the", "animals", "injected.", "Hybrids", "containing", "the", "introduced", "chromosome", "18", "but", "was", "significantly", "reduced", "in", "several", "of", "the", "tumor", "reconstitute", "cell", "lines.", "Introduction", "of", "chromosome", "5", "had", "little", "to", "no", "effect", "on", "responsiveness,", "whereas", "transfer", "ot", "chromosome", "18", "restored", "responsiveness", "to", "some", "degree.", "Our", "findings", "indicate", "that", "while", "multiple", "defects", "defects", " ", "but", "inhibition", "of", "tumorigenicity", "is", "accomplished", "by", "correction", "of", "any", "single", "defect", "via", "chromosome", "transfer." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Carcinogenesis is a multistage process that has been characterized both by the activation of cellular oncogenes and by the loss of function of tumor suppressor genes. Colorectal cancer has been associated with the activation of ras oncogenes and with the deletion of multiple chromosomal regions including chromosomes 5q, 17p, and 18q. Such chromosome loss is often suggestive of the deletion or loss of function of tumor suppressor genes. The candidate tumor suppressor genes from these regions are, respectively, MCC and/or APC, p53, and DCC. In order to further our understanding of the molecular and genetic mechanisms involved in tumor progression and, thereby, of normal cell growth, it is important to determine whether defects in one or more of these loci contribute functionally in the progression to malignancy in colorectal cancer and whether correction of any of these defects restores normal growth control in vitro and in vivo. To address this question, we have utilized the technique of microcell-mediated chromosome transfer to introduce normal human chromosomes 5, 17, and 18 individually into recipient colorectal cancer cells. Additionally, chromosome 15 was introduced into SW480 cells as an irrelevant control chromosome. While the introduction of chromosome 17 into the tumorigenic colorectal cell line SW480 yielded no viable clones, cell lines were established after the introduction of chromosomes 15, 5, and 18. Hybrids containing chromosome 18 are morphologically similar to the parental line, whereas those containing chromosome 5 are morphologically distinct from the parental cell line, being small, polygonal, and tightly packed. SW480-chromosome 5 hybrids are strongly suppressed for tumorigenicity, while SW480-chromosome 18 hybrids produce slowly growing tumors in some of the animals injected. Hybrids containing the introduced chromosome 18 but was significantly reduced in several of the tumor reconstitute cell lines. Introduction of chromosome 5 had little to no effect on responsiveness, whereas transfer ot chromosome 18 restored responsiveness to some degree. Our findings indicate that while multiple defects defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.
[ 2, 12559, 1977, 43, 13564, 3857, 2106, 2585, 1988, 2258, 2252, 4378, 2321, 2007, 1920, 2936, 1927, 3689, 18582, 1930, 2007, 1920, 3257, 1927, 2347, 1927, 2798, 9241, 2628, 18, 7820, 2539, 2258, 2252, 2458, 1956, 1920, 2936, 1927, 6520, 18582, 1930, 1956, 1920, 5541, 1927, 3137, 9220, 3451, 2710, 8597, 25, 1055, 16, 2752, 1034, 16, 1930, 2654, 1055, 18, 2427, 5597, 3257, 1977, 3868, 12855, 1927, 1920, 5541, 2014, 3257, 1927, 2347, 1927, 2798, 9241, 2628, 18, 1920, 6610, 2798, 9241, 2628, 2037, 2144, 3451, 2032, 16, 2763, 16, 11772, 1930, 19, 2014, 9187, 16, 5105, 16, 1930, 24649, 18, 1922, 3238, 1942, 2520, 2342, 4339, 1927, 1920, 3272, 1930, 3299, 3531, 3286, 1922, 2798, 4380, 1930, 16, 6113, 16, 1927, 2791, 2024, 2905, 16, 2176, 1977, 2715, 1942, 3415, 3053, 6007, 1922, 2340, 2014, 2253, 1927, 2144, 6971, 4672, 9346, 1922, 1920, 4380, 1942, 10248, 1922, 7820, 2539, 1930, 3053, 6820, 1927, 2967, 1927, 2144, 6007, 24423, 2791, 2905, 2285, 1922, 3596, 1930, 1922, 3597, 18, 1942, 4640, 2052, 3863, 16, 2038, 2162, 7079, 1920, 4778, 1927, 10572, 1992, 17, 3434, 5597, 3856, 1942, 11959, 2791, 2616, 8597, 25, 16, 2752, 16, 1930, 2654, 9864, 2460, 10664, 7820, 2539, 2094, 18, 4950, 16, 5597, 2461, 1982, 6373, 2460, 26018, 2094, 1966, 1925, 17458, 2285, 5597, 18, 2679, 1920, 6935, 1927, 5597, 2752, 2460, 1920, 19282, 7820, 2024, 2823, 26018, 8193, 2239, 8978, 7251, 16, 2024, 3557, 1985, 4379, 2256, 1920, 6935, 1927, 8597, 2461, 16, 25, 16, 1930, 2654, 18, 16607, 3165, 5597, 2654, 2032, 17312, 2551, 1942, 1920, 7213, 2823, 16, 3417, 2690, 3165, 5597, 25, 2032, 17312, 4493, 2037, 1920, 7213, 2024, 2823, 16, 3301, 2858, 16, 16115, 2996, 16, 1930, 12129, 15827, 18, 26018, 17, 5597, 25, 16607, 2032, 4937, 7657, 1958, 28946, 16, 2679, 26018, 17, 5597, 2654, 16607, 5074, 11240, 6552, 3861, 1922, 2673, 1927, 1920, 3555, 5624, 18, 16607, 3165, 1920, 6373, 5597, 2654, 2308, 1982, 2567, 3028, 1922, 2980, 1927, 1920, 2798, 10808, 2696, 2024, 3557, 18, 6935, 1927, 5597, 25, 2430, 5082, 1942, 2239, 2495, 1990, 10854, 16, 3417, 3856, 7608, 5597, 2654, 10680, 10854, 1942, 2673, 4647, 18, 2342, 3056, 3579, 1988, 2679, 3137, 6007, 6007, 2308, 3523, 1927, 28946, 1977, 13677, 2007, 6820, 1927, 2967, 2957, 7374, 3454, 5597, 3856, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 9, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
22899730
[ "Our", "results", "show", "that", "the", "prevalence", "of", "BRAF", "mutations", "in", "CRC", "differs", "by", "patient", "and", "tumor", "characteristics", "and", "suggest", "that", "the", "association", "between", "BRAF", "status", "and", "CRC", "survival", "may", "differ", "by", "some", "of", "these", "factors." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
Our results show that the prevalence of BRAF mutations in CRC differs by patient and tumor characteristics and suggest that the association between BRAF status and CRC survival may differ by some of these factors.
[ 2, 2342, 2274, 2146, 1988, 1920, 4077, 1927, 11346, 3527, 1922, 8223, 11457, 2007, 2774, 1930, 2798, 3779, 1930, 3220, 1988, 1920, 3279, 2192, 11346, 3642, 1930, 8223, 3298, 2278, 2129, 2007, 2673, 1927, 2144, 2790, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
25029911
[ "As", "a", "novel", "candidate", "metastasis", "suppressor", "gene,", "Nasopharyngeal", "carcinoma-associated", "gene", "6", "(NGX6)", "is", "involved", "in", "cellular", "growth,", "cell", "cycle", "progression", "and", "tumor", "angiogenesis.", "Previous", "studies", "have", "shown", "that", "NGX6", "gene", "is", "down-regulated", "in", "colorectal", "cancer", "(CRC).", "However,", "little", "is", "known", "about", "its", "transcriptional", "regulation." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
As a novel candidate metastasis suppressor gene, Nasopharyngeal carcinoma-associated gene 6 (NGX6) is involved in cellular growth, cell cycle progression and tumor angiogenesis. Previous studies have shown that NGX6 gene is down-regulated in colorectal cancer (CRC). However, little is known about its transcriptional regulation.
[ 2, 1966, 43, 4008, 6610, 5967, 9241, 2359, 16, 22142, 5373, 17, 2458, 2359, 26, 12, 4375, 20649, 13, 1977, 3286, 1922, 3689, 2905, 16, 2024, 4048, 4380, 1930, 2798, 8244, 18, 2555, 2351, 2162, 2522, 1988, 4375, 20649, 2359, 1977, 3292, 17, 4335, 1922, 7820, 2539, 12, 8223, 13, 18, 2406, 16, 5082, 1977, 3171, 3001, 2496, 5224, 3640, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]
23797718
[ "BRAFV600E", "immunohistochemistry", "facilitates", "universal", "screening", "of", "colorectal", "cancers", "for", "Lynch", "syndrome." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome.
[ 2, 11346, 25606, 2283, 1021, 9101, 11374, 10321, 4449, 1927, 7820, 5717, 1958, 27452, 4741, 18, 3 ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
[ -100, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -100 ]